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ABSTRACT 
 
Neonatal meningitis Eschericha coli (NMEC), a sub-pathotype of extra intestinal 
E. coli (ExPEC), is one of the most common causative agents of neonatal bacterial 
meningitis (NBM).  NBM is a devastating disease affecting neonates less than four weeks 
old, causing acute onset of sepsis and invasion of the central nervous system.  Without 
treatment, NBM is almost certainly fatal, but early intervention and empiric treatment, as 
well as new broad spectrum antibiotics, have reduced the mortality rates from 32% in 
1975 to as low as 8.5% in the United States.   
Recent studies have greatly improved knowledge of NMEC pathogenic 
mechanisms by characterizing multiple NMEC virulence factors; however, nearly all 
experiments were performed using a single NMEC strain, RS218, and its derivative 
mutants.  Broader studies examining larger populations of NMEC have begun to show 
that some of the virulence factors critical for NMEC RS218 pathogenesis are uncommon 
in other NMEC, while other virulence factors identified using NMEC RS218 are present 
in multiple E. coli sub-pathotypes and even non-pathogenic E. coli.  Such findings beg 
the questions, what genes define the NMEC sub-pathotype? How diverse are members of 
the NMEC sub-pathotype? And can another NMEC strain, other than NMEC RS218, 
serve as a more representative prototype of the NMEC group?  
Additionally, other studies have found that some Avian Pathogenic E. coli 
(APEC) strains can cause NBM in the rat model of human disease, while some NMEC 
are able to cause disease in the day-old chick model of avian colibacillosis.  Such 
findings suggest that NBM and avian colibacillosis, caused by ExPEC, could be zoonotic 
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diseases, a contention that requires further study for both the benefit of human and animal 
health.  
In sum, these studies challenge current definitions of ExPEC sub-pathotypes.  
This dissertation focused on on generating high quality genomic and plasmid sequences 
for a random population of NMEC and analyzed these data in silico to better define the 
NMEC sub-pathotype.   
Initial characterization began with sequence and assembly of a population of 48 
NMEC strains from the United States and Europe, searching for novel virulence and 
resistance factors. As part of this comparative study of NMEC strains, a polymorphic 
analysis of ubiquitous E. coli genes, thought to contribute to the pathogenesis of ExPEC 
diseases, but also present in non-pathogenic E. coli was undertaken.  Analysis of the 
results showed that genes that are strongly linked to NMEC virulence in the literature, 
such as cnf1, sfaS, sfaC, and traJ, were found in less than 50% of the NMEC surveyed, 
while the K1 capsule, aslA, chuA, and papX were found in more than 75% of the strains.  
Analysis of the sequences of the ubiquitously occurring and well-known genes, fimH and 
ompA, demonstrated that both harbored polymorphisms in sites important to protein 
activity and substrate binding.  When these NMEC polymorphisms were compared to 
those in other ExPEC sub-pathotypes (namely, uropathogenic E. coli and APEC), distinct 
polymorphic patterns were discerned that differentiated members of the three ExPEC 
sub-pathotypes.  This finding is quite intriguing, as these genes encode a number of key 
processes in ExPEC pathogenesis, suggesting that they could explain tissue tropism, host 
specificity and/or capability of a strain to cause a specific syndrome.  Future study will 
need to be done to explore these issues.    
viii 
 
In addition to comparative analysis of NMEC chromosomes, the large putative 
virulence plasmids of several NMEC isolates were sequenced and compared to define the 
core and pan-plasmidome of NMEC.  These sequences were also scanned for novel 
virulence and resistance genes, and the sequences compared to one another and to 
plasmids sequences of other ExPEC sub-pathotypes.  Results show NMEC plasmids 
sequenced in this dissertation were genetically similar to plasmids of APEC strains.  
Neither core plasmid polymorphism phylogenies nor differences in plasmid-borne genes 
could distinguish APEC plasmids from NMEC plasmids. 
Finally, high quality complete genomic sequences for NMEC O18 and APEC 
O18 strains with zoonotic potential were generated.  NMEC O18 is a highly virulent 
NMEC strain able to cause similar disease in the rat model of human neonatal meningitis.  
Interestingly, it lacks cnf1 and traJ, both thought to be crucial for NMEC pathogenesis.  
APEC O18 is highly virulent in chick embryos and day old chicks but is also highly 
virulent in the rat model of human meningitis.  This paper reports the first sequence of an 
APEC O18 strain causing neonatal meningitis at the same level as NMEC O18 and 
RS218.
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CHAPTER 1.  INTRODUCTION 
 
Escherichia coli is a diverse and prolific species of bacteria commonly found in 
the environment and inhabiting the gastrointestinal tract of mammals (1).  While most E. 
coli are harmless, some possess the potential to cause disease in humans and animals.  To 
distinguish between different disease causing isolates, pathogenic E. coli are commonly 
grouped into pathotypes, or groups of isolates that cause the same or similar disease.  One 
group of these pathotypes, Extra intestinal Pathogenic E. coli (ExPEC), are able to cause 
a range of diseases in different hosts, including colibacillosis in poultry (2), urinary tract 
infections, neonatal meningitis and sepsis in humans and other animals such as neonatal 
pigs and dogs (3-5).  Collectively, these diseases are a major burden to the healthcare 
costs annually (6).  Urinary tract infection (UTI) symptoms  caused approximately 10.5 
million doctor visits, and approximately 2.5 million emergency room visits, in the year 
2007 alone (7).  After including costs for lost work productivity, the estimated costs of 
UTI infections in the United States is estimated at 3.5 billion dollars per year as of 2007 
(2, 6-8).   
General Biology of E. coli 
Escherichia coli are Gram-negative, facultative anaerobic, rod-shaped bacteria 
belonging to the family Enterobacteriaceae of the Proteobacteria phylum (1).  
Escherichia. coli are non-spore forming and may be motile through possession of flagella 
(9), occurring in a peritrichous arrangement, or more rarely through twitching motility 
mediated by pili (10).  Growth temperature ranges and optimums vary based on each 
individual strain; however, optimal growth occurs at 37°C (1) with the typical strain 
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showing at least minimal sustained growth between 7°C and 42°C (11, 12).  Classically, 
E. coli are identified by their ability to ferment lactose, produce β-glucosidase, and 
convert tryptophan to indole, while not possessing cytochrome C oxidase, creating an 
oxidase test negative phenotype (1, 13, 14). 
Escherichia coli possess a wide range of metabolic genes and commonly use a 
diverse set of carbon sources including D-galactose and glycerol (1), as well as some 
amino such as α-ketoglutarate acid, pyruvate, or oxaloacetate (1).  Escherichia coli 
generally can metabolize amino acids and grow in minimal media containing as few 
chemicals as glucose, ammonium chloride, magnesium sulfate, and calcium chloride 
(15); however, some strains may be natural or engineered auxotrophs (16, 17).  
Engineered E. coli auxotrophs are often used for research, including metabolic 
engineering (18), unknown gene function research (19), or specific amino acid synthases 
to select for a specific mutation or maintenance of genetic components such as a 
recombinant plasmid (17, 19). 
A major agent of genetic diversity in E. coli is horizontal gene transfer of mobile 
genetic elements, most notably, plasmids (20), and less commonly through phage 
transduction of genes (21).  Plasmids, as well as bacteriouphage islands, are a common 
feature of many E. coli (21); both often contain critical components for E. coli 
pathogenesis (20, 22).  In general, E. coli are not competent under laboratory conditions 
(23), and are unable to maintain imported extracellular DNA due to nucleases such as 
those encoded by recBCD that degrade linear DNA strands; however, degraded 
nucleotides can be used for cellular processes (24).  Given that E. coli does possess genes 
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to import linear DNA, some have suggested E. coli may be naturally competent in 
conditions that are currently unknown (25-28).   
Genetic Diversity of E. coli 
E. coli, including, Shigella spp., is an exceptionally diverse genus of bacteria and 
shows genetic heterogeneity, with genomes ranging in size from 4.56 Mbp to 5.7 Mbp, a 
20% difference in size (29).  This size difference hints of the diversity of E. coli.   In the 
1960s, genomic relatedness was determined using DNA-DNA hybridization, with a 
cutoff of 70% being set to delineate species (30).  Since that time, other methods, such as 
restriction length polymorphism analysis and pulse field gel electrophoresis analysis have 
been used to determine genetic relatedness (31), but perhaps, the most definitive means to 
assess E. coli strains’ relatedness is the use of full genome sequence comparisons (32-
34).   
Initial genomic comparisons were carried out for the first publicly available E. 
coli sequences, pathogenic E. coli strains EDL933 (EHEC) released in 2001, CFT073 
(UPEC), released in 2002, and the laboratory adapted strain MG1655 released in 1997 
(35).  These results showed a 39.2% overlap in protein coding genes, giving the first 
indications that E. coli were a much more diverse species than previously thought, and 
well beyond the theoretical 70% cutoff value (36).  Further, it was found upon 
comparison of fragmented sequences of UPEC strains J96 and 536 that the evolution of 
UPEC had occurred independently from different lineages (36). 
A later study examining 61 sequences of non-pathogenic and pathogenic E. coli 
of various pathotypes revealed that the maximum common E. coli genome was 
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approximately 1 Mbp (~20%), less than the difference in genome size between some E. 
coli strains (21).  Further, this study showed a pan-genome of 16,000 gene families, while 
the typical E. coli genome only contains 5,000 genes.  Given the large diversity among E. 
coli strains and the recognition that virulence in E. coli had evolved independently 
multiple times, scientists in E. coli genomics cast doubt on the idea that single or small 
groups of representative isolates could adequately represent the species or pathotype (29). 
E. coli can be classified in several ways, e.g., by assignment to serotype or 
serogroup, pathotype, multilocus sequence type and phylogenetic group (29, 32, 37-40).  
Originally, serotype was based on recognition of antigen of the lipopolysaccharide of the 
outer membrane, K capsular antigen and flagellar, and/or H antigen by certain antisera 
(41); whereas, serogroup was based on the recognition of O antigen alone (1).  Recently, 
however, a shift is occurring away from more time-consuming and difficult serology 
methods to faster and sometimes cheaper DNA-based or computational methods (42).  
Serotyping of E. coli strains is performed by agglutination assay of specific rabbit 
antisera in response to multiple antigens on the bacterial cell surface: the O antigen, 
(n~173) consisting of the oligosaccharide portion of the exterior lipopolysaccharides 
coating the bacterial surface LPS; the K antigen, (n~60) consisting of the acidic capsular 
polysaccharide layer; and the H antigen, (~53) characterizing the flagella (1, 37, 41).  The 
combination of O, K and H typing is commonly known as a serotype, while the O antigen 
type itself is referred to as the serogroup (41).  This method historically has suffered 
many difficulties, as cross reactions between O types were common, as well as cross 
reactions between O and K antigens (1, 41), in part due to some capsular chains being 
bound to the cell membrane (41).  Even though cross reactions exist, serotyping has 
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historically been used in E. coli since 1943 when it was described by Kauffmann (43), 
and has provided typing based on surface factors involved in virulence processes such as 
attachment and immune recognition.  Serotyping is still a common and important method 
of discriminating among E. coli strains. 
Though a large number of serotypes exist, fewer serotypes or serogroups are 
commonly observed in infections, and can be associated with specific pathotypes.  The 
most well-known example being enterohemorrhagic E. coli strain serotype O157:H7, 
though serogroups O26, O103, O111, and O145 currently comprise the majority of 
EHEC strains (44).  This pattern holds true to varying degrees for all pathogenic E. coli, 
with example pathotypes containing common serogroups including enteroaggregative E. 
coli (O3, O15, O44, O86, O119, and O125) (1), UPEC (O1, O2, O4, O6, O7, O8, O16, 
O18, O25, and O75) (45), NMEC (O1, O6, O7, O8, O18, and O83) (46), and APEC (O1, 
O2, O25, O78 and O119) (47). 
The phylogenetic type of an E. coli strain was initially based on multilocus 
enzyme electrophoresis (MLEE) profiles of 10 genes, with each disease or pathotype 
using individual numbering systems for enzyme mobility; which were eventually 
combined into a single system in 1997 (31).  Studies by Whittam with MLEE were the 
first to statistically link frequencies of 16 possible observed allele combinations to four 
major alleles, A, B, C, and D, (48), with occasional subvariations including E, B1, B2, 
B3, and A1 (49, 50).    These groups were refined to A, B1, B2 and D following inclusion 
of more and diverse samples (51). These alleles have since been termed Phylogenetic 
groups, and PCR amplification methods eventually replaced MLEE due to PCR needing 
fewer control strains, and being overall simpler and faster (39).  Today, seven major 
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phylogenetic groups exist (A, B1, B2, C, D, E, F), and PCR is a primary method for 
phylogenetic typing, correctly assigning 99.5% of strains to the proper phylogenetic 
group (40).  Finally multilocus sequence type (MLST) methods specific to E. coli with 
publicly accessible databases were first published in 2005 (52).  Currently two E. coli 
MLST databases are widely used, and may also be used to determine phylogenetic typing 
(40, 52, 53).   The recently formed phylogenetic group C further separates A and B1 
strains, while group E enhances resolution between phylogenetic group B1 and group D.  
Phylogenetic group F represents a sister lineage to B2 strains. 
Such groupings give real insight into the structural make-up of different E. coli 
types and their evolutionary background.  Typically, enterohemorrhagic E. coli belong to 
phylogenetic groups B1 and E (54), while human ExPEC belong to phylogenetic group 
B2, and to a lesser extent, D (55, 56).  APEC were previously classified as primarily 
phylogenetic groups A and D (~30%) with some belonging to groups B1 and B2 (~15%) 
(56); however, this classification is not correct.  Original study of E. coli strains using 
MLEE and the original 4 phylogenetic group PCR were based only on a small collection 
of environmental and non-pathogenic isolates combined with isolates from human UTI 
and meningitis  (39).  Excluding E. coli causing animal disease, such as APEC, biased the 
phylogenetic typing scheme, and thus many APEC were improperly classified as groups 
A and D.  Reclassification of APEC using the revised 7 major group method (40) resulted 
in massive APEC phylogenetic group rearrangements, with phylogenetic groups A and D 
shrinking to 11% and 5% incidence respectively. Phylogenetic group C became the most 
commonly occurring group among APEC (27%), while the incidence of groups B1 and 
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B2 stayed consistent with group F joining at 20%.  Less than 1% of strains grouped as 
untypeable (unpublished data). 
Intestinal Pathogenic E. coli 
Intestinal pathogenic E. coli, also known as diarrheagenic E. coli, are a subset of 
pathogenic E. coli causing disease localized to the mammalian intestines.  Currently, 
intestinal pathogenic E. coli are categorized into six major pathotypes.  Each uses unique 
mechanisms to cause disease in the gastrointestinal tract of humans and some other 
animals, but utilize common host factors to cause disease.  Many of these pathogenic 
strategies, such as cellular adhesion and invasion, are shared between intestinal 
pathogenic E. coli, but the mechanisms used to accomplish these goals differ and are not 
covered in this literature review. 
Extraintestinal Pathogenic E. coli 
Intestinal pathogenic E. coli are a diverse set of organisms containing functionally 
distinct mechanisms enabling the organisms to cause disease.  These distinct 
mechanisms, though hybrid strains do exist, allow classification into functional groups 
and types of intestinal pathogenesis.  In the case of ExPEC, heterogeneous distribution of 
virulence genes between pathotypes is common, making distinctions between ExPEC 
pathotypes more problematic and more reliant on the syndrome, tissue and host from 
which the strain was isolated (46, 57-59).  There are, however, some trends in the 
presence of virulence genes by an ExPEC sub-pathotypes, likely emphasizing the 
important of certain traits in causing certain syndromes.  Notably, many ExPEC 
pathogens possess a limited number of serotypes, and commonly produce sialic acid type 
K1 capsules. 
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Uropathogenic E. coli (UPEC) 
UPEC are the most common causative agent of urinary tract infections throughout 
the world, accounting for an estimated 80% of all urinary tract infections (6, 60).  Urinary 
tract infections predominantly affect women with as many as 40% of women 
experiencing a urinary tract infection at some point in their lives (6, 7).  Once a urinary 
tract infection occurs in an individual, the person is more likely to become infected again, 
with a quarter of patients experiencing a second infection less than a year after clearance 
of the first infection (61).  In general, UPEC infections are not life threatening; however, 
UPEC infection can ascend through the urinary tract to the kidneys, resulting in 
pyelonephritis, or into the bloodstream causing urosepsis (62).  The latter two infections 
are quite serious, as pyelonephritis may cause permanent kidney scarring and loss of 
function or renal failure (60, 63), while the mortality rate from urosepsis ranges from 20 
to 40% and is likely higher in older patients, patients with diabetes, or other 
complications involving the urinary tract (64). 
It is thought that UPEC originate from the colon, contaminate the perineum and 
enter the urethra to cause infection (60).  From there, UPEC ascend through the urethra to 
enter the bladder, where they cause cystitis (60).  While in the bladder, attachment to host 
cells, followed by cellular invasion, is critical for UPEC virulence (65).  Strong 
attachment to host cells is especially critical to avoiding washout due to large volume 
discharges (66).  For these reasons some UPEC strains possess more than 10 fimbrial 
operons to facilitate adherence, including P, type 1, F1C, S, Dr, and M (67).  Certain 
UPEC fimbriae undergo phase variation in response to environmental cues (68).  Phase 
variation within populations is also hypothesized to increase the probability of adherence 
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to different host tissues (68).  Studies have shown that while many fimbriae exist in 
UPEC, type 1 fimbriae are largely responsible for adherence to uroepithelial cells, with 
the fimbrial tip adhesin, FimH, playing a critical role in UPEC colonization (66, 67, 69).  
FimH adhesin largely mediates mannose recognition, including recognition of mannose-
containing glycoproteins on the surface of host cells (70).  This variability in FimH 
facilitates binding to a wide range of host receptors and substrates, and may contribute to 
a wider host range (71).  Interestingly, though fimH is a critical virulence gene for UPEC, 
it is found widely among pathogenic and non-pathogenic strains of E. coli alike (71), 
begging the question, are there differences in the structure of fimH in pathogenic and 
non-pathogenic E. coli enabling the pathogens to adhere to a broad spectrum of host 
receptors, potentially increasing host range as well as possibly reducing immunogenic 
residues?  Recently, further analysis of fimH variants from urinary tract infections 
showed amino acid residues critical for mannose binding were conserved, but variable 
amino acid sequences were found in other positions.  Analysis of these polymorphisms 
showed different fimH alleles possess significantly different levels of binding and 
adherence when assayed in the same genetic background, and indicated specific 
polymorphisms common for UPEC strains may increase binding fitness in the urogenital 
environment (69).   
Toxins are also important virulence factors in UPEC pathogenesis and include 
those encoded by hlyA, vat/sat, and cnf1 (65).  UPEC, distinct from some intestinal 
pathogenic E. coli, do not commonly possess a functional type III secretion system.  
Therefore, UPEC toxins are either excreted through type I or IV secretion systems or 
encode their own transport (65).  HlyA is an α-hemolytic protein toxin, which causes cell 
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lysis at high concentrations, while at lower concentration its effects on host cells are more 
subtle, causing activation of MAP kinase, calcium oscillation signals, histone 
modification, and inactivation of the Akt kinase (65, 72).  Vat, also known as Sat (73), is 
a serine protease autotransporter protein toxin shown to cause elongation of urinary 
epithelial cells and loosening of cell junctions, which is thought to increase cellular 
invasion or entry into the bloodstream (73).  Cnf1 is a dermonecrotic toxin, so named for 
its first recognized phenotypes (74).  Cnf1 binds to epithelial cell laminin receptors and 
heparin sulfate proteoglycan co-receptors, where it is endocytosed and transported to the 
endosomal compartment (75).  Once in the endosomal compartment, the toxin inserts into 
the endosomal membrane, and the active toxin is released into the cell cytoplasm, where 
it causes constitutive activation of Rho GTP-binding proteins (76), inducing stress fiber 
formation, which plays a critical role in multiple cellular adhesion processes (cell 
adhesion, barrier formation, tissue structure) and cell shape (77). 
Evasion of host immune responses is another critical component for UPEC 
pathogenesis in the urinary tract.  Immune evasion is in many cases mediated by adhesins 
and toxins.  Examples of this include FimH-mediated adherence and invasion of bladder 
epithelial cells (78) or HlyA-deactivation of Akt kinase, causing reduced vesicle 
trafficking, inflammation signaling, and decreased leukocyte phagocytosis and 
chemotaxis (65) (79).  Genes more specific for immune invasion include O antigen LPS 
genes and LPS recycling genes, which function to reduce pathogen-associated molecular 
patterns (80), biofilm synthesis and export by capsular genes such as kpsT and kpsM (81).  
The outer membrane protein OmpA is also thought to increase serum resistance.  Studies 
examining UPEC strains and NMEC strains have shown OmpA facilitates binding to 
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macrophages as well as invasion of macrophages (82), binds complement protein C4bp to 
facilitate degradation of complement proteins C3b and C4b (83), and prevents 
transcription of pro-inflammatory cytokines and chemokines by preventing 
phosphorylation and degradation of inhibitor κB proteins (84). 
Nutrient acquisition genes comprise another group of important UPEC virulence 
genes.  In the extraintestinal environment, key nutrients for growth are often sparse, 
making nutrient acquisition a critical need (85-87).  Indeed, many host mechanisms exist 
to reduce the bioavailability of key nutrients such as iron, and iron sequestration is a 
common defense mechanism for host-pathogen resistance (86).  While most bacteria 
contain mechanisms to acquire iron from the environment (88), UPEC possesses multiple 
systems, commonly encoding the siderophore systems for enterobactin, salmochelin, 
aerobactin, and yersiniabactin (65).  In addition, UPEC commonly possess the sit metal 
transport operon and the chu operon, which encodes utilization of heme or hemoglobin 
(65), as opposed to intestinal or non-pathogenic E. coli, which generally encode fewer 
metal acquisition operons (89).  Despite its high affinity for iron, enterobactin is bound 
and inactivated by the human protein lipocalin 2, while salmochelin (encoded by the iro 
operon) has been shown to function in the presence of lipocalin 2 and may enhance in-
vivo iron acquisition (90).  UPEC’s possession of multiple uptake systems likely 
enhances fitness in many environments, including the urinary tract, and offers functional 
redundancy to promote survival in inhospitable environments (87, 91, 92).   
Similar to iron acquisition, UPEC strains frequently carry other metabolic genes 
hypothesized to confer a selective advantage for survival, including D-serine deaminase, 
tetrathionate reductase, urease, and α-ketoglutarate import and utilization enzymes (19, 
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93, 94).  These genes are often found on genomic islands, which have been horizontally 
transferred from other pathogenic species, such as Salmonella enterica subsp. enterica 
serotype Typhimurium (tetrathionate reductase) or Helicobacter pylori (Urease).  D-
serine deaminase and its associated permease and regulatory protein are encoded by the 
operon dsdCXA.  This operon allows for the import and utilization of D-serine as a sole 
carbon and nitrogen source converting by D-serine to pyruvate and ammonia.  While D-
serine is found in nature, it is much less common than the L-amino acid enantiomers (95).  
In humans, it is found only in brain, plasma, and urine, which are locations associated 
with ExPEC infection, and UPEC has been shown to alter gene regulation in response to 
D-serine exposure (96).  Tetrathionate reductase, encoded by the gene cluster ttrABCRS, 
encodes a two component regulatory system (94) as well the ttr gene cluster is shown to 
facilitate anaerobic B12-dependent utilization of tetrathionate to thiosulfate, which can 
further be reduced to H2S in Salmonella; however, genes responsible for the further 
reduction to H2S are not generally present in E. coli.  This absence is a trait commonly 
used in metabolic identification of E. coli (1).  More recent studies of tetrathionate in S. 
Typhimurium have shown that tetrathionate mediated resistance to NADPH oxidase and 
nitric oxide radicals, both of which are commonly used by the host to inhibit or eliminate 
bacterial infections (97). 
Urease has been previously reported to be produced by some pathogenic E. coli 
strains such as EHEC (98), but often the urease-producing operon ureDABCEFG is 
incomplete or non-functional.   Some UPEC strains, containing the Helicobacter genomic 
island, can produce urease under anaerobic, nitrogen-limited conditions, generating an 
alternative nitrogen source, and promoting inflammation of the bladder epithelium (19).  
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Finally, an α-ketoglutarate utilization system has been shown to be present in 70% of a 
sample of UPEC (19).  This system encodes a two-component regulatory system that 
responds to α-ketoglutarate and regulates expression of 8 genes (19). The 5-carbon 
compound α-ketoglutarate is a citric acid cycle intermediate and is used as an organic 
anion in the concentration gradients of the kidney’s proximal tubules for antiport of 
organic anions (99).  Chlamydia trachomatis, another intracellular uropathogenic 
organism, also uses α-ketoglutarate for metabolism (100).  This organism actually lacks 
the citric acid cycle enzymes citrate synthase, aconitase, and isocitrate dehydrogenase 
which are necessary to generate α-ketoglutarate (100).  These genes when taken together 
show specific adaption to the urinary tract environment, and with multiple mechanisms of 
nutrient acquisition by these organisms. 
In conclusion UPEC strains are heterogeneous and diverse, possessing a multitude 
of virulence factors and other characteristics that contribute to uropathogenesis.  While 
intestinal pathogenic E. coli often possess well-defined virulence genes encoding well-
characterized mechanisms for virulence, UPEC strains possess a large variety of 
virulence genes.  Many of these virulence genes encode functionally similar or redundant 
proteins, while other genes encode virulence factors essential or significantly contributing 
to pathogenesis.  These are shared with non-pathogenic E. coli and are present in many E. 
coli sub-pathotypes.  These indicate the population of UPEC likely possesses a large 
collection of virulence factors not all of which are necessary for pathogenicity, and 
distinct combination of virulence genes are likely responsible for variable severity in 
UPEC infections (29).   
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Avian Pathogenic E. coli 
Avian pathogenic E. coli (APEC) is a common sub-pathotype of ExPEC and one 
of the leading causes of mortality and morbidity in the poultry industry for broiler and 
layer chickens, turkeys, ducks and other production birds worldwide (101, 102).  APEC 
cause colibacillosis, which is an umbrella term encompassing a wide range of systemic 
and localized infections (101).  Some of the most severe infections for the health of the 
bird involve septicemia, while other infections like cellulitis or Swollen Head are more 
localized (103).  Regardless, these conditions are responsible for major losses to the 
poultry industries due to mortality, morbidity, loss of production and condemnations 
(104).  
APEC is thought to enter the bird in different ways such as via inhalation of 
contaminated dust, through abraded skin, via cracks in embryonating eggs, and by 
retrograde movement of bacteria from the cloaca (2).  Colibacillosis is likely to be both a 
primary and secondary disease depending on the strain of APEC involved in infection 
(101). Some APEC are very well equipped pathogens while others are likely relatively 
avirulent, but because of predisposing infections, are able to cause disease (101).  Such 
predisposing conditions can involve high ammonia and dust levels or previous infection 
with pathogens such as Mycoplasma spp. or Newcastle virus (105).  These stressors are 
thought to weaken the respiratory immune response and/or damage tracheal cilia, 
enhancing APEC’s ability to colonize the respiratory tract (2, 105).   
When APEC use a respiratory route in infecting birds, the organisms are inhaled, 
and colonize the upper and lower respiratory tract to cause various respiratory conditions 
such as airsacculitis.  From there, APEC can gain entry to submucosal tissue, where they 
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cross to the bloodstream by unknown mechanisms.  Once in the bloodstream, APEC 
cause septicemia, leading to development of pericarditis and perihepatitis.  As a result, 
APEC may be isolated from the brain, spleen, and bone of infected birds, as well as in 
blood, urine and synovial fluid (106).    
APEC’s diversity is also seen in its possession of known and putative virulence 
genes, with APEC varying greatly in their virulence genotypes (102, 107, 108).  APEC 
harbor a wide range of potential virulence factors, but their role of these factors in 
pathogenesis is unknown.  Similar to UPEC, APEC often demonstrate redundancy of 
virulence genes performing critical functions during pathogenesis (87, 109, 110).  APEC 
strains frequently possess large ColBM and ColV plasmids which carry pathogenicity 
islands that contain many virulence genes known to contribute to APEC pathogenesis 
(102, 111-115).  These plasmids serve as one of the most distinguishing characteristics 
separating APEC strains from fecal E. coli strains and are present in over 90% of APEC 
strains.  As in UPEC, virulence factors of APEC can be broadly categorized as adhesins, 
toxins, and metabolic genes. 
Adhesins represent one of the better-defined APEC virulence factors, although 
much is still unknown.  The fimbrial proteins Stg, P, Yqi, type I, Curli, E. coli common 
pilus, as well as the temperature sensitive hemagglutinin protein Tsh, have all been 
implicated as important APEC virulence factors, with one study finding the Tsh protein 
as well as the Yqi and Stg pili are necessary for APEC colonization of the trachea and 
lung specifically (116).   The other adhesion factors have been shown to reduce virulence 
in strains, their specific functions are yet unknown (117).  The adhesion and invasion 
gene, ibeA, has also been implicated as an APEC virulence gene, functioning to resist 
16 
 
oxidative stress (118), but again, this gene is only found in 14% of APEC strains 
(unpublished data). 
According to genotypic studies of APEC strains, toxins are uncommon in APEC 
strains, with the only confirmed toxin being the vacuolating autotransporter toxin Vat 
also found in UPEC (47, 73).  The vat gene’s prevalence in APEC strains is 
approximately 33% (102) and was found to be an unreliable target for APEC 
identification.  While this gene is uncommon, another study has found that in APEC 
strain Ec222 the vat gene is necessary for pathogenesis (119); however given the absence 
of this gene in a large majority of APEC strains indicates this toxin is not a requisite 
virulence factor.  Further, the lack of novel toxin discovery through sequencing of 
multiple diverse APEC, and the high incidence of virulence plasmids not containing 
toxins, suggests toxins may not generally be involved in APEC pathogenesis. 
APEC, like other ExPEC, possess unique metabolic genes to help survive in the 
extra intestinal environment.  Iron acquisition genes are exceptionally prevalent in APEC, 
with aerobactin, salmochelin, and enterobactin commonly found in APEC strains.  The 
salmochelin and aerobactin siderophores are commonly found on the aforementioned 
virulence plasmids.  APEC also commonly possess the putative metal transport gene 
cluster sitABC (96%).  Further studies show deletion of the phosphate-specific phosphate 
transport system operon pstCAB gene causes a reduction in virulence in APEC (120); 
however, this study indicated that the pst operon may serve as a primary phosphate 
sensor, and mutation of the pst operon causes constitutive expression of the pho operon.  
The pho operon is a two-component regulatory operon known to regulate 39 genes, and 
potentially regulates an additional 98 genes. Though this gene deletion causes 
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attenuation, interference with one or more regulatory systems precludes correlating the 
attenuation with a specific gene.  Another study found expression of nirC from strain 
SCI-07 in vivo was significantly upregulated compared to growth in regular serum and 
hypothesized the gene may play a role in downregulating macrophage production of 
nitric oxide.   Further analysis showed the gene played a highly nuanced role in virulence 
causing increased expression of the nitric oxide resistance genes hmp and ytfE, but 
overall decreasing motility important for colisepticemia, in the wild type strain.  Net 
effects of nirC deletion delayed infection onset, but increased duration of infection, lesion 
score, and increased bacterial counts in organs and macrophage. 
Overall, the specific mechanisms of APEC pathogenesis are poorly understood, 
and efforts to determine pathogenicity are hampered by strains possessing diverse genetic 
content.  Some characterization has been performed to test specific toxins and adhesins 
and metabolic genes, but the majority of this work has been done for genes that are not 
pervasive in APEC strains.  Currently, common and confirmed APEC virulence factors 
include only the ColV/ColBM plasmids that encode siderophores, a putative adhesin gene 
tsh, and a putative serum resistance gene iss.  Much study is still needed to determine 
specific pathogenic mechanisms for APEC. 
Neonatal Meningitis causing E. coli 
Neonatal meningitis E. coli (NMEC) is the final major sub-pathotype of extra 
intestinal E. coli and is primary focus of this dissertation.  NMEC is included here for 
completion. A detailed analysis of NMEC pathogenesis begins on page 24. 
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Virulence Plasmids of Extra-Intestinal Pathogenic E. coli 
Plasmids are extrachromosomal self-replicating genetic elements most often 
transferrable, and are categorized either by their incompatibility/replicon type or, for E. 
coli plasmids, by which colicins are produced (20).  Plasmids are often a source of 
genetic diversity in microbial populations, granting enhanced fitness under specific 
environmental conditions by providing accessory metabolic, virulence, and/or resistance 
genes.  Virulence plasmids are known to play a significant role in the pathogenesis of 
many E. coli including ETEC, EAEC, EIEC, EHEC, EPEC, and ExPEC (20) and in 
general code for toxins, adhesins, and/or other virulence enhancing factors.  Among 
ExPEC pathotypes, virulence plasmids are defining characteristics of APEC and NMEC, 
generally 90% or greater prevalence has been reported (112).  Virulence plasmids are less 
common in UPEC, with indications they may be present in approximately 30% of UPEC 
strains (121). Three major types of plasmids are found in ExPEC:  colicin V producing 
(ColV), colicin B and M producing (ColBM), and Vir plasmids, all of which are in the 
RepFIB/FIIA incompatibility groups (20), and generally carry virulence genes.  This 
section will detail the proposed virulence phenotypes of ColV, ColBM, and Vir plasmids, 
highlighting that although these virulence phenotypes and genes are common, they are 
not shared by all plasmids. 
Colicin V and Colicin BM Virulence Plasmids 
ColV virulence plasmids have been associated with ExPEC virulence since 1962, 
when an F-type plasmid producing colicin V was found to be transferrable (122).  Later 
studies suggested colicin V may be a virulence factor (123); however transposon 
mutagenesis showed that other plasmid genes, and not colicin, were likely responsible for 
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enhanced virulence (124).  More contemporary studies show ColV plasmids not only 
enhance virulence but can cause pathogenic gain of function in previously non-
pathogenic strains (114). 
The colicin plasmids, named for their antimicrobial phenotypes (125), 
characteristically possess genes to produce colicin, a colicin immunity protein conferring 
immunity to carried colicin, and cell lysis proteins or other export systems (125). Colicin 
proteins are categorized by the colicin’s outer membrane surface receptor and the inner 
membrane receptor (126), and function as antimicrobial peptides affecting closely related 
bacterial species (125).  While colicins are diverse and effective antimicrobials, 
transcription and translation of lysis protein-encoding genes in the operon is lethal.  
Transcription and translation of the colicin operon causes a buildup of colicin and lysis 
proteins in the cytoplasm.  Lysis proteins are transported to the outer membrane via type 
II secretion (125).  A critical concentration of lysis protein in the outer membrane causes 
OmpLA activation and expression of proteases to lyse the cell (125).  Once released, 
colicin B binds to the enterobactin receptor protein FepA and is transported to the 
periplasm (126), where it forms a pore in the target cell disrupting membrane stability 
and ion gradients causing cell death (126).  Colicin M instead binds to outer membrane 
ferrichrome receptor FhuA, and once in the cytoplasm colicin M degrades peptidoglycan 
precursors preventing peptidoglycan synthesis and eventually causing cell death (127).  
Colicin V is unique in that it utilizes an ABC transporter operon, cvaABCI, instead of 
lysis proteins allowing non-lethal colicin release (128).  Colicin V enters host cells via 
interaction with the outer membrane protein Cir (129).  Once inside the periplasm, 
Colicin V interacts with inner membrane protein SdaC forming a pore and destroying 
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membrane potential (129). It has been shown that colicins themselves provide little 
benefit to strains during pathogenesis, instead they likely assist plasmid-containing 
strains to compete in the intestinal tract or other environments, while other genes 
contribute to virulence (124).   
Siderophores and metal acquisition genes are common in ColV plasmids, usually 
encoding both the aerobactin and salmochelin siderophores, as well as the sitABCD 
operon.  Aerobactin and salmochelin, as previously described, are functional siderophore 
systems in the presence of lipocalin 2 in human serum, and are upregulated in human and 
avian serum.  When the aerobactin and salmochelin operons are deleted, a corresponding 
reduction in virulence has been noted in avian models (87).  The sit operon encodes 
divalent metal ion transporters, and are similar to chromosomally-encoded sit genes 
located in some Shigella species (130).  In vitro studies have shown the sitABCD operon 
cloned into siderophore deficient strains can orchestrate the uptake and utilization of iron 
in the presence of iron chelator 2,2’-dipryidyl, by non-specific transport that instead 
favors manganese binding (131).  Furthermore, the sitABCD gene cassette was shown to 
increase resistance to oxidative stress in the presence of hydrogen peroxide (131). 
Transport systems are also commonly found in ColV plasmids.  As one may 
expect, colicin export genes cvaABC are encoded by these colicin producing plasmids, as 
well as etsABC, encoding a putative iron transport system; however no functional 
characterization of these genes has occurred (109). 
Finally, outer membrane proteins and toxins are regularly encoded on ColV-type 
plasmids.  The membrane proteins OmpTp and Iss are routinely found on plasmids, as 
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well as the temperature-sensitive hemagglutinin autotransporter Tsh.  The ompTp gene 
encodes an outer membrane protein homologous to ompT in the omptin family of outer 
membrane proteases.  OmpT was suggested to play a role in activating other secreted 
proteins (132) while in vitro study has shown OmpT can degrade antimicrobial peptides 
present in human urine (133).  The observant reader may have noted, OmpT and OmpTp 
are highly homologous but distinct proteins, with one present on the ColV and ColBM 
virulence plasmids, while the other is chromosomally encoded.  Overall these genes are 
highly homologous, but changes in ompT orthologs are known to affect substrate 
specificity.  The exact property of the OmpTp protease have yet to be determined.  The 
Iss protein(s) are closely related to chromosomally-encoded lambda phage gene bor, 
encoding an outer membrane protein.  Three allelic variants of iss exist, as well as bor, 
and while bor is only found chromosomally, iss can be plasmid or chromosomally 
located, and their confusion has hampered studies to this day (134).  The Iss protein is a 
dominant feature of APEC, and studies utilizing Iss as a vaccine target show Iss may 
provide protection against heterogeneous APEC strains (135, 136).  While these results 
are promising, surprisingly little research exists regarding the specific mechanism by 
which the iss gene facilitates enhanced serum survival (137).  The tsh gene of ColV 
plasmids encodes a temperature-sensitive hemagglutinin gene autotransporter, able to 
bind to red blood cells, purified hemoglobin, and fibronectin and collagen IV, while also 
having protease function with the ability to cleave casein, though an in vivo target that 
has not identified (138).  ColBM plasmids are similar in nature to the ColV plasmids 
previously discussed; however, ColBM plasmids have been discovered that are missing 
typical regions found on ColV plasmids, and instead contain insertions of antimicrobial 
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resistance genes, and may be a potential source of virulence and resistance plasmid 
hybrids (113). 
Vir Plasmids 
Vir plasmids were discovered in 1974 and belong to the replicon types 
RepFIB/FIIA.  Vir plasmids are found in E. coli associated with healthy bovine as well as 
in intestinal and extra intestinal disease of humans and animals, but are much rarer than 
ColV and ColBM plasmids (139).  Overall three genes are characteristic of Vir plasmids: 
CNF-2, type III cytolethal distending toxin (CDT), and P17b fimbriae with a fourth 
putative fimbrial gene cluster tibAC.  CNF-2 protein is thought to function similarly to 
chromosomally encoded CNF-1, and is commonly found in E. coli isolated from healthy 
cattle.  The type III cytolethal toxin is encoded by three genes, two of which facilitate 
host cell delivery (140).  Once inside the host cell, CDT functions as a DNase, causing 
double-stranded DNA breaks (140, 141).  The F17 fimbria encoded by NTEC plasmids is 
a variant of a chromosomally encoded E. coli common fimbriae.  Recent studies have 
shown F17 fimbrial variants exist which are associated with septic disease in lambs and 
calves, but distinct from F17a, F17c, and F17d variants associated with bovine ETEC, 
bovine diarrhea/sepsis, and human UPEC respectively (142). 
Neonatal Bacterial Meningitis 
Neonatal bacterial meningitis (NBM) is an insidious disease affecting 1 in every 
1,000 children during the first 4 weeks of life.  Without treatment, NBM is normally 
fatal.  Clinically NBM is diagnosed by bacterial presence in the blood, and presence of 
bacteria, antigens, or pleocytosis in the cerebrospinal fluid (CSF) (143).   NBM onset is 
sudden and characterized by rapid progression of symptoms, faster than culture results 
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can be obtained.  Current medical literature suggests empiric treatment with penicillin 
and cefotaxime/aminoglycosides modified if necessary according to local prevalence of 
meningitis causing organisms and antimicrobial resistance. After obtaining positive 
culture identification and sensitivity reports, treatment protocols are optimized to the 
specific organism and its antimicrobial susceptibilities (144). 
Bacterial meningitis presenting in the first two days to week of life is indicative of 
vertical transmission from the mother, termed early-onset, while infection after the first 
week up to 4 weeks suggests acquired infection, termed late-onset (145).  Infections may 
also be categorized by the gestational age of the child.  Term birth indicates a gestation 
age > 37 weeks, late preterm gestation age is between 33 and 37 weeks inclusive, and 
preterm gestational age is < 33 weeks (8).   
A major French observational study over a seven year period from 2001 through 
2007 in 114 pediatric wards throughout France is currently the best source of NBM data 
for incidence, disease onset data, and cultured causative organisms.  This study found 
children born at term comprised the majority of observed infections (n=423, 78%), with 
late-preterm following (16%), and the lowest incidence of infection in pre-term birth 
(6%); however term births account for 90% of births, while late-preterm account for 
approximately 8%, and preterm 2%, indicating infants born before a GA of 37 weeks are 
more susceptible to NBM (8, 146).  The major causative organisms of NBM in order of 
incidence have been identified as Group B streptococci (~60%)(GBS) and E. coli (~30%) 
with isolated incidence of infection seen by other Gram-negative bacilli, other Gram-
positive cocci, Neisseria meningitidis (~5%), and Listeria monocytogenes (~3%) (147).  
Group B streptococci were causative agents in both early-onset and late-onset NBM, but 
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E. coli prevalence rises from 18% to 33% from early-onset to late-onset, with a 
corresponding drop in GBS incidence.  Overall mortality was 13% with higher mortality 
rates observed in pre-term infants (26%) compared to full term infants (10%), while low-
weight infants regardless of term have higher mortality rates (25%) than appropriate 
birthweight infants (12%) (8). 
Follow-up studies on nine-year-old survivors of NBM reveals the harsh effects of 
NBM on surviving neonates: neurological sequelae.  NBM survivors were compared to 
non-NBM case children with the same birthdate and sex from the same doctor.  Mortality 
before the age of 9 occurred in 3% of NBM cases while 20% of NBM survivors 
presented with moderate or severe neurological sequelae, with a higher incidence in 
lower weight and gestational neonates at time of infection. No corresponding control 
children presented with these sequelae.  Severe impairments included cerebral palsy with 
loss of function or several functions such as, significant learning disabilities, and mental 
retardation determined by an IQ < 55 (100 indicating normal). Moderate impairments 
were defined by mild cerebral palsy, learning impairment determined by IQ between 55-
69 inclusive, partial paralysis, and hearing loss. 
Pathogenesis of Neonatal Meningitis causing E. coli 
The pathogenic process of NMEC has been almost entirely determined through 
study of the NMEC strain RS218.  Strain RS218 is a highly pathogenic strain isolated 
from a human case of neonatal meningitis, and this strain or its derivatives are used solely 
in most experiments characterizing NMEC (46, 82, 84, 148-167). 
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Current models of NMEC pathogenesis derived from study of strain RS218 
indicate infection begins through perinatal exposure of NMEC to the digestive tract (4, 
158).  Once exposed, NMEC are thought to travel the digestive system to the intestinal 
tract, where they attach to enterocytes and are transcytosed into the bloodstream (158).  
In the bloodstream, NMEC utilizes multiple mechanisms to evade the innate immune 
system.  NMEC strains generally produce capsular glycoproteins mimicking human 
glycoproteins (K1) (148), as well as O-acetyltransferase via the neuO gene, providing 
variation of the O antigen (168).  In addition to mimicry, NMEC are resistant to killing 
by the classical complement system (83).  While in the bloodstream, NMEC also invade 
and replicate in macrophages (82, 166), evading the immune system while 
simultaneously disrupting pro-inflammatory cytokine production, further obfuscating 
infection (84).   
Proliferation of the bacteria in the bloodstream and macrophage quickly 
overwhelms the immune response and causes acute bacteremia (4).  Bacteremia exposes 
high numbers of bacteria to the blood-brain barrier (BBB), a tight junction of 
microvascular endothelial cells separating the central nervous system (CNS) from the 
blood stream (153).  NMEC strains are thought to adhere to the cells of the BBB, and 
through the actions of adhesins (169), toxins (152, 153, 164), and invasion factors (151), 
invade human brain microvascular endothelial cells (HBMEC) and astrocytes to 
transverse the BBB into the CNS, or to cross the BBB inside macrophages, utilizing a 
Trojan horse mechanism to enter the CNS (163, 170).  In either case, NMEC in the CNS 
further invade astrocytes resulting in meningitis. 
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During the process of pathogenesis NMEC must adhere to multiple cell types, 
survive the host immune response, invade immune and epithelial cells, and cross the 
BBB.  Current knowledge of these processes and their mechanisms are described in the 
following sections. 
Role of adhesion and invasion in neonatal meningitis E. coli 
Adhesion is an important factor for bacterial pathogens (71, 142, 171), and 
NMEC is no different.  NMEC pathogenesis involves adhesion and invasion of three 
major cell types, Enterocytes, Monocytes, and HBMEC. 
Enterocyte Adhesion and Invasion 
The first step in the current model of NMEC pathogenesis necessitates transit 
from the intestines to the circulatory system.  As a naturally enteric organism, E. coli 
often express fimbriae and pili for adhesion to intestinal epithelial cells (71).  Pathogenic 
bacteria may also carry additional proteins specific for binding to proteoglycans 
expressed on host cells (4).  In ETEC, the Tia protein is one example, while NMEC 
possess the hek gene.  The hek gene facilitates binding to all proteoglycans, with 
preference for heparin-containing proteoglycans (158), and is sufficient to cause in vitro 
invasion of enterocytes when cloned into a non-pathogenic K-12 strain, but is less 
invasive than wild-type RS218 (158).  The genes ompA as well as ibeA are also 
implicated in enterocyte binding and invasion, but their roles are not yet defined (158). 
Monocyte Adhesion and Invasion 
NMEC strains bind to monocytes and macrophage cells both in vitro and in vivo 
(82).  In the case of strain RS218, studies in macrophage-depleted mice have shown the 
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absence of macrophage fully attenuates RS218 (166) though studies on NMEC 58 in this 
dissertation show little to no invasion of macrophage in vitro (unpublished data).  The 
major binding protein showing contribution to macrophage adherence is the outer 
membrane protein OmpA (82).  The OmpA protein is known to bind receptor CD64A, 
and is necessary for RS218 binding and subsequent invasion of the macrophage cell line 
RAW 264.7 (160).  The CD64A protein is an Fc-gamma receptor expressed by all 
macrophages that binds monomeric IgG antibodies, and in conjunction with gamma-
chain binding, facilitates macrophage killing (160).  When OmpA is bound to the CD64A 
protein, significantly less gamma chain association to CD64A is seen in comparison to 
OmpA negative mutants, demonstrating OmpA can block CD64A-mediated macrophage 
binding to inhibit a lethal macrophage phenotype.  Further OmpA possess a higher 
affinity for the CD64A binding site than IgG, and can supplant bound IgG, causing 
further resisting host immunity (160). 
Blood-Brain Barrier Adhesion and Invasion 
Not all neonatal pathogens or pathogenic E. coli strains are capable of causing 
meningitis, which is defined by bacterial invasion of the CNS (172).  To transverse the 
blood-brain barrier, NMEC utilize type 1 fimbriae and OmpA proteins as the major 
adherence factors.  The FimH tip adhesion of type 1 fimbriae interacts with host cell 
CD48; the binding phenotype is lost when antibodies to either FimH or CD48 are added 
in vitro (155).  CD48 is thought to mediate adhesion and interactions between human 
epithelial and immune cells, and may be involved in macrophage transcytosis through the 
BBB (173).  
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The OmpA protein, as previously implicated with enterocytes and macrophages, 
also contributes to BBB binding.  OmpA interacts with N-acetylglucosamine regions of 
glycoproteins on the BBB, specifically glycoprotein 96, also present on colonocytes (156, 
157, 162, 174, 175), and is necessary for HBMEC binding and invasion, but may not be 
sufficient itself (167).  This glycoprotein specificity is not surprising as many other 
pathogens including Clostridium difficile, Neisseria gonorrheae, Staphylococcus aureus, 
and adherent-invasive E. coli are known to interact with gp96 (167, 176-180). 
OmpA and FimH by themselves may not be sufficient for invasion of the BBB, as 
other factors are thought to assist in the process (148, 151, 152, 161, 164).  Some of the 
most common and best studied factors include: IbeA, Cnf1, and the K1 capsule, which 
are all though to contribute to invasion of the blood brain barrier.  The ibeA gene encodes 
an invasion factor uncommon in all ExPEC, but associated with NMEC and found in 
approximately half of strains (181).  The IbeA protein binds vimentin (170), an 
intermediate filament protein normally expressed in host cell cytoplasm, but may 
circumstantially express on the cell surface under certain conditions.  IbeA was shown as 
sufficient to cause low-level invasion of HBMEC in vitro (182).  While another study has 
shown IbeA binding of vimentin greatly increases PNM transversal of the BBB, perhaps 
suggesting a Trojan horse mechanism for CNF invasion facilitated by IbeA (163).    
Though aslA is known to contribute to invasion of HBMEC, the specific mechanisms by 
which aslA increases invasion are currently unknown (150). 
Immunomodulation by neonatal meningitis E. coli 
During infection, NMEC are exposed to factors of the neonatal immune system.  
Though not fully mature, the immune system still presents significant challenges which 
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bacteria must overcome.  NMEC use the properties of mimicry, complement resistance, 
macrophage invasion, and cytokine modulation to avoid the killing effects of the immune 
system. 
Antiphagocytic Properties and Mimicry 
The K1 capsule is the major agent of host mimicry in meningitis E. coli.  The K1 
capsule is composed of poly-α-2,8-N-acetylneuraminic acid, a sialic acid (183, 184).  
Sialic acid and its structural derivatives are common on the surface of mammalian and 
avian cells, and function as self-recognition molecules for many cellular processes (185).  
Mimicry of the sialic acid residues obscures NMEC from the immune system, and 
downregulates complement deposition on the cell surface (186), as well as downregulates 
macrophage phagocytosis of cells (184). 
Complement resistance 
Complement resistance in NMEC is mediated by multiple factors.  The K1 
capsule interferes with complement factor C3 binding to the cell surface (186).  In 
addition to the capsule, the NMEC outer membrane protein OmpA also interferes with 
the complement system.  OmpA binds complement binding protein 4 (C4bp), which acts 
as an inhibitor of C3b (187).  C3b is a required component for both the classical and the 
mannose-binding lectin pathway of complement killing (188).  Studies of neonatal cord 
blood have shown decreased concentrations of alternative complement factors, especially 
factors P and B (189).  These factors are essential for activation of the alternative 
pathway of complement (188).  Adults possessing genetic mutations causing deficiency 
or inactivation of complement factor P show increased susceptibility to bacterial 
infections, especially acute meningeal infections such as Neisseria meningitidis (189).   
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Macrophage invasion 
Macrophages present another facet of NMEC immune invasion.  NMEC have 
been shown to adhere to, and invade, macrophage cells.  Replication of type strain RS218 
in macrophage requires expression of the OmpA protein (82).  NMEC invade 
macrophage, form vacuoles and resist macrophage killing.  While inside these vacuoles 
NMEC continue to replicate relatively unhindered.  Eventually prolific bacterial 
replication damages and kills the infected macrophage, which bursts and rereleases 
NMEC into the bloodstream (82). 
Cytokine Modulation 
While inside monocytes, disruption of cytokine production occurs by preventing 
the inhibitor kappa B protein from phosphorylation, preventing transcription of nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-kB) (84), which normally acts 
in macrophage as a transcriptional regulator activating pro-inflammatory cytokines such 
as interleukin 1 and tumor necrosis factor α (190).  Simultaneously, NMEC induce 
production of BclXL, causing downregulation of cellular apoptosis (154).  The 
combination of multiple complement resistance factors, resistance to macrophage killing, 
and inhibition of pro-inflammatory cytokine production allows NMEC to effectively 
evade early immune response to infection and multiply undetected, which causes 
bacteremia that overwhelms the host immune system.  The high level bacteremia 
facilitates NMEC exposure to the blood brain barrier, where NMEC eventually invade 
and cause meningitis (4). 
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Aims and Significance of this Research 
A considerable body of research has been established on NMEC pathogenesis and 
mechanisms of specific virulence genes during the course of infection.  Almost all of this 
research has been performed using the strain RS218, or its derivatives (82-84, 148-150, 
152-167, 174, 191).  Given the diverse nature of E. coli, researchers already doubt the 
ability of single isolate-based studies to represent an E. coli pathotype (29).  More 
troubling, the strain RS218 contains uncommon virulence factors, such as the cnf1 gene 
present in less than 5% of NMEC strains isolated from human cases (181).  The cnf1 
gene is widely considered a critical virulence component for BBB invasion, and is found 
more commonly in UPEC strains (27.5%) (Unpublished data).  Finally, a diverse group 
of NMEC serotypes, phylogenetic groups, and genotypes have been observed in NMEC 
strains, indicating understanding of NMEC pathogenesis is likely too narrow and does 
not accurately reflect the entire NMEC sub-pathotype. 
Previous studies in population genetics of ExPEC frequently reveal heterogeneous 
distributions of virulence factors in ExPEC, with no genes solely associated with specific 
sub-pathotypes, as well as similar prevalence of known virulence factors (181).  Attempts 
to characterize the ExPEC pathotypes have met limited success, and generally distinguish 
ExPEC sub-pathotypes from fecal E. coli, but cannot distinguish between all ExPEC sub-
pathotypes (46, 58, 110).  The current classification system for ExPEC is solely based on 
disease caused by the isolated E. coli, but studies have shown some ExPEC can cause 
diseases of multiple sub-pathotypes (58).  Select APEC strains cause high mortality 
meningitis in the neonatal model, while some NMEC strains also cause colibacillosis in 
day-old chicks (58); unfortunately no studies have examined UPEC strains in the avian or 
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meningitis models.  Due to these genomic similarities, and examples of virulence in 
multiple disease models and hosts, studies now suggest APEC, NMEC, and UPEC are 
potentially zoonotic pathogens (58, 59, 110, 134, 181, 192, 193). 
With these factors in mind, this dissertation sought to use a whole-genome 
epidemiological approach to define a sample population of NMEC strains.  We 
sequenced 49 randomly selected NMEC genomes isolated from clinical cases of neonatal 
meningitis from the United States and the Netherlands, and compared incidence and 
polymorphisms of virulence genes.  Our ultimate goal was to determine whether a larger 
sample of NMEC strains coincided with the current model of NMEC pathogenesis.  
Further, we sought to better define the characteristic RepFIIA/FIB plasmids of NMEC 
strains, and if and how NMEC plasmids differ from one another and from other ExPEC 
sub-pathotype plasmids.  Finally, we provided whole-genomic sequence of strains APEC 
O18 and NMEC O18, which were both previously characterized and shown to cause 
disease in both the neonatal meningitis and colibacilosis models.  
This research characterized the broadest collection of NMEC strains to date.  The 
work is significant due to use of genomic population-based knowledge to NMEC study, 
and challenges, deeply entrenched concepts of NMEC research based on a single strain 
and thus do not account for the overall diversity within population of NMEC.  Finally this 
research significantly increased the amount of genomic data from NMEC publicly 
available, and contributed the first sequenced ExPEC strains confirmed to cause disease 
in both human and avian disease models.  
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Organization of this Dissertation 
This dissertation is organized in journal format with 6 chapters.  Chapter 1 
contains a literature review of Escherichia coli.  Chapter 2 addresses chromosomal 
components of NMEC virulence as well as the distribution and variance of these factors 
within a sample population of sequenced NMEC strains.  Chapter 3 follows the 
chromosomal study with a genomic survey of NMEC virulence plasmids, including their 
common and accessory genome, effects on NMEC virulence, and phenotypes conferred.  
Chapter 4 details the complete genome announcement of NMEC strain O18, possessing 
the ability to cause mortality in chick embryos and in the rat model of meningitis.  
Chapter 5 contains the genome announcement of APEC strain APEC O18, which shares 
the O18 serotype with NMEC O18 and causing similar mortality rates to NMEC O18 in 
both chick embryos and neonatal rats.  Chapter 6 concludes with a summary of the 
dissertation. 
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Introduction 
Disease-causing Escherichia coli strains can be grouped into two broad categories 
based on the tissues in which they cause disease.  They are, intestinal pathogenic E. coli 
and extraintestinal pathogenic E. coli (ExPEC) (1).  The ExPEC pathotype encompasses 
several sub-pathotypes including uropathogenic E. coli (UPEC) (1), septicemia-causing 
E. coli (2), neonatal meningitis E. coli (NMEC) (2) and avian pathogenic E. coli (APEC) 
(3).  Among these, the NMEC sub-pathotype is one of the least studied despite the fact 
that NMEC are one of the most common causative agents of neonatal bacterial meningitis 
(4). 
Neonatal bacterial meningitis is a severe and rapidly progressing infectious 
disease of children during the first four weeks of life (5).  During the course of disease 
the host generally develops profound bacteremia which leads to invasion and 
inflammation of the meninges (4).  Observed hospital mortality rates due to bacterial 
meningitis in neonates range from in 28% to 40% regardless of etiology (4).  However, if 
left untreated, this disease is usually fatal with survivors suffering severe lifelong 
neurologic sequelae (6, 7).   
NMEC pathogenesis includes initial attachment and invasion of enterocytes in the 
small intestine.  Attachment of NMEC to enterocytes is mediated by the fimbrial tip 
adhesin FimH, of the E. coli type 1 pilus (8, 9).  Following attachment, the protein Hek 
interacts with host proteoglycans to facilitate transcytosis of the enterocytes where it 
gains access to the bloodstream.  Following entry into the bloodstream, NMEC must 
survive the bloodstream.  Bloodstream survival is facilitated by is mediated by K1 
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capsule (10) and OmpA (11-13).  OmpA, a bacterial outer membrane protein coded by 
the ompA gene, is a multifunctional protein that interrupts activation of the complement 
cascade via the classical pathway through binding of the C4b-binding protein (13).  
OmpA further facilitates bloodstream survival by modulating cytokine release following 
macrophage invasion (11, 14).  The resulting bacteremia brings NMEC in contact with 
the blood-brain barrier (BBB) (2).  Transcytosis of the BBB, frequently mimicked in 
vitro using human brain microvascular cell lines (HBMEC), is a complex process and is 
thought to involve the protein products of fimH, ompA, cnf1, and ibeA.  The FimH protein 
mediates binding of NMEC to the human brain microvascular endothelial cells and is 
hypothesized as necessary for HBMEC invasion, recognizing host protein CD48. FimH 
binding to CD48 causes host cell calcium release and is thought to activate RhoA to 
induce cytoskeletal rearrangement (15).  The protein OmpA is shown to facilitate binding 
to HBMEC to the stress protein Ecgp (16-19).  OmpA also induces phosphorylation of 
signal transducer and activator of transcription 3 protein (STAT3), activating RhoA and 
Rac1 to induce cytoskeletal rearrangements (19), but full downstream effects are not 
known.  These studies clearly suggest OmpA contributes to NMEC virulence but it is still 
unclear if they are necessary, as ompA-negative strain RS218 mutants still invade 
HBMEC in vitro (20).  The protein IbeA binds to brain microvascular epithelial cell 
surface protein vimentin where it induces PMN transmigration into the cerebrospinal 
fluid (21-23) leading to “Trojan horse” invasion; however, the IbeA protein in other 
studies was shown to be sufficient to cause bacterial invasion of HBMEC without PMN 
interaction (24).  
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Much of what we know about NMEC pathogenesis is based on study of a single 
NMEC strain, RS218, a member of the O18:K1:H7 serotype (8-11, 14, 15, 17, 23, 25-
29).  This organism was the first NMEC characterized and has served as a useful model 
of the NMEC sub-pathotype for some time, with this strain and its derivatives being the 
focus of most NMEC research to date.  However, recent studies have underscored the 
challenges in generalizing what we know of this strain to the entire NMEC sub-pathotype 
(30, 31).  For instance, recent population-based studies have shown that some virulence 
factors important to NMEC RS218’s pathogenesis, such as cnf1, are absent in the 
majority of NMEC strains (30, 31).  Similarly, multiple strains deviating from the 
O18:K1 serotype, which is thought to typify the NMEC, have also been reported (32, 33).  
Finally, the virulence factors thought to be essential to NMEC pathogenesis, ompA and 
fimH, are ubiquitous in E. coli (34-41), are a known virulence factors of UPEC, 
enterotoxigenic E. coli, and also a hypothesized virulence factor of adherent-invasive E. 
coli further complicating the relationship between sub-pathotypes and virulence factors 
(42, 43).   
Recently, more broad-based studies have identified a substantial degree of overlap 
between NMEC and APEC in their pathogenic mechanisms and abilities to cause disease 
in models of human and avian disease.  This has led to the hypothesis that NMEC, which 
cause human meningitis, might be derived from Avian Pathogenic E. coli (APEC), an 
important and widespread pathogen of poultry (44) and contaminant of retail poultry 
meat (45).   
Currently, sequence data on NMEC strains are limited.  The first publicly 
available NMEC-sequenced strain was IHE3034 published in 2010 (46).  Strain IHE3034 
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has lost a large virulence plasmid, which have been found in other strains to contribute to 
virulence (28, 32).  NMEC strain CE10 was the second publically available sequenced 
NMEC genome (33).  CE10 was sequenced due to the novelty of containing a type III 
secretion system and atypical O7 serogroup (33).  NMEC strain RS218 was publically 
released as whole genome shotgun sequences in August of 2015, and is described as the 
prototypical Escherichia coli K1 strain causing meningitis (47).  While study of these 
genomes has greatly enhanced knowledge of meningitis caused by E. coli, population 
studies have shown they may not fully account for the diversity of NMEC strains, or 
represent typical NMEC strains (30, 31, 45, 48).   
Here, we seek to broaden the community’s access to genomic data from a diverse 
group of NMEC, define the NMEC core and accessory genomes, and ascertain if these 
differ greatly from what is known about the APEC core and accessory genomes.  In 
addition, we will attempt to discern through phylogenomic analysis the relationship of 
NMEC to that of other ExPEC. 
Materials and Methods 
Bacterial Strains and Selection.  From a group of 91 E. coli strains isolated from 
cases of human neonatal bacterial meningitis in the United States and the Netherlands, 48 
isolates were selected via random number generation for whole genome sequencing.  
These NMEC had been previously serogrouped at the E. coli reference center 
(Pennsylvania State University), genotyped for virulence and resistance genes by PCR 
(49), and assigned to phylogenetic groups (50) (Table 1). 
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Table 1.  Strains sequenced and used in this study and their general properties. 
 
Strain Serotype Capsule Phylogroup Cluster () Hemolysis Source
NMEC 2 18 1 B2 8 γ This study
NMEC 3 18ac 1 B2 8 γ This study 1 5 A 3 1 6
NMEC 6 6 1 B2 4 γ This study 2 1 B1 2 2 3
NMEC 7 - 1 B2 8 β This study 6 2 B2 43 3 1
NMEC 8 83 1 B2 8 γ This study 7 5 C 3 4 5
NMEC 11 - 1 B2 8 γ This study 9 1 D 1 5 1
NMEC 14 7 80 C 2 γ This study 12 3 E 1 6 6
NMEC 15 18 1 B2 8 γ This study 14 2 F 5 7 5
NMEC 16 83 1 B2 8 γ This study 16 1 8 23
NMEC 18 18 1 B2 8 γ This study 18 9 9 1
NMEC 19 - 1 B2 8 γ This study 18ac 1
NMEC 20 7 - D 1 γ This study 21 2
NMEC 22 - 1 B2 8 γ This study 23 1
NMEC 23 7 1 F 1 γ This study 25 1
NMEC 26 21 - B2 6 β This study 45 2
NMEC 27 12 - A 1 γ This study 78 1
NMEC 28 18 - B2 8 γ This study 83 6
NMEC 29 135 1 B2 7 γ This study 135 1
NMEC 30 18 1 B2 8 γ This study 166 1
NMEC 34 - 1 F 9 γ This study auto 2
NMEC 35 166 1 B2 4 γ This study - 10
NMEC 36 14 1 B2 7 γ This study
NMEC 37 14 1 B2 8 γ This study
NMEC 38 18 1 B2 8 γ This study
NMEC 40 83 1 B2 5 β This study
NMEC 42 auto - B2 8 γ This study
NMEC 43 - - B2 8 γ This study
NMEC 45 23 1 B1 3 β This study
NMEC 49 auto 1 B2 8 γ This study
NMEC 52 25 10 B2 4 γ This study
NMEC 55 9 36 C 2 γ This study
NMEC 57 83 1 B2 8 γ This study
NMEC 58 18 1 B2 8 γ This study
NMEC 59 1 1 B2 6 β This study
NMEC 60 1 1 B2 8 γ This study
NMEC 65 83 1 B2 8 γ This study
NMEC 67 83 1 B2 8 γ This study
NMEC 70 - 1 B2 7 γ This study
NMEC 71 21 unknown B2 6 γ This study
NMEC 72 - unknown B2 6 β This study
NMEC 73 - unknown B1 2 γ This study
NMEC 74 - unknown E 1 γ This study
NMEC 81 12 unknown B2 6 β This study
NMEC 82 1 unknown B2 7 γ This study
NMEC 83 1 unknown F 4 γ This study
NMEC 84 16 unknown B2 4 γ This study
NMEC 86 12 unknown A 1 γ This study
NMEC 89 45 unknown B2 7 γ This study
NMEC 91 7 unknown F 1 γ This study
RS218 18 1 B2 6 β CP007149
S88 45 1 B2 8 + CU928161.2
CE10 7 1 D (F*) unknown unknown NC_017646
UTI89 18 1 B2 - + NC_007946 
CFT073 6 2 B2 - + AE014075 
APEC O1 1 1 B2 - γ NC_008563
APEC O78 78 unknown C - γ NC_020163
IMT5155 2 1 B2 - unknown NZ_CP005930
DH1 85 12 C - γ NC_017625
W3110 - (16) 12 A - γ AP009048
Strain Origin
Netherlands US France Germany Unknown
O-Type Phylogroup Cluster ()
Distribution
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DNA Isolation and Library Preparation.  Bacterial strains for sequencing were 
removed from -80°C glycerol stock, struck to MacConkey agar plates and incubated 
overnight at 37°C.  Isolated single colonies were picked and inoculated into 2ml of Luria 
Bertani broth (Becton Dickinson Franklin Lakes, NJ) and incubated at 37°C with shaking 
for 18 hours.  Bacterial cells were pelleted by centrifugation at 7000xg for 10 minutes 
and resuspended in buffer containing 0.25mg/ml RNaseA and 2µg/ml Proteinase K.  
Cells were lysed by heating at 80°C for 90 minutes.  DNA was harvested from the lysate 
using ChargeSwitch gDNA mini bacteria kit (Life Technologies Carlsbad, CA), and the 
DNA yields were quantified using a Qubit fluorometer dsDNA HS kit (Life Technologies 
Carlsbad, CA).  Genomic libraries were prepared using the Nextera XT kit (Illumina San 
Diego, California) for paired end barcoded samples.  Genomic library DNA was 
quantified by qPCR using KAPA library quantification kits (Kapa Biosystems 
Wilmington, MA), and normalized to equivalent amplifying concentrations.  
Genome Sequencing and Assembly.  Genomic libraries were sequenced on an 
Illumina MiSeq Desktop Sequencer using Miseq Reagent Kit v2 for 500 cycles (paired-
end 250) at the USDA National Animal Disease Center (Ames, Iowa).  Two runs, each 
with 24 indexed libraries were sequenced.  Resultant reads were de-multiplexed, and 
resultant fastq files were assessed using the FastQC program to assess reads for quality, 
duplications, and per base sequence content.  Read positions with an average Phred 
quality scores below 18, duplications, or average read position base content skewed 10% 
or more from overall average were trimmed. 
De-multiplexed reads were assembled using the SPAdes Genome Assembler 
version 3.5.0 for Linux (51) using assembly options for paired-end reads and Burrows 
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Wheeler Aligner mismatch correction.  Post-assembly quality assessment was performed 
using the software Quast (52) to determine contig sizes, N50, and assembly size.   
Sequencing Treatment and Statistics.  Following post-sequencing quality 
trimming and adapter removal, the mean read length for sequenced genomes was 220 
base pairs per end.  The mean number of non-scaffolded contigs, greater than 1,000 base 
pairs, was 122.   The mean genome size of sequenced strains was 5,006,856 base pairs.  
Percentage GC averaged 50.60%.  Individual genome assembly statistics are described in 
Table 2. 
Whole Genome Alignment and Phylogeny.  NMEC genome assemblies from 
this study were compared to previously sequenced NMEC genomes (n = 4), genomic 
sequences from other ExPEC (n = 5) and laboratory strains (n = 2).  Previously 
sequenced strains used in this study included NMEC strains CE10, RS218, IHE3034, and 
S88; APEC strains IMT5155, APEC O78, and APEC O1; UPEC strains UTI89 and 
CFT073; and the laboratory strains, E. coli DH1 and W3110.   Perl scripts were used to 
remove assembled contigs less than 800 base pairs in size or having less than 8-fold 
coverage.  Harvest genomics tools version 1.1.2 (53) were used to align and visualize the 
core and pan genome of these strains using Muscle.  Single Nucleotide Polymorphisms 
(SNPs) from aligned core genomic regions were removed and concatenated.  Whole 
genome SNPs were used to generate a maximum likelihood phylogenetic tree using 
FastTree2 (54). 
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Table 2.  Sequencing and Assembly Statistics. 
 
Strain Contigs Large Contigs Largest Contig (bp) Total Length (Mb) GC% N50
NMEC 2 239 137 239,391 5.21 50.64 81594
NMEC 3 252 95 452,385 5.28 50.68 196320
NMEC 6 567 347 102,147 4.96 50.94 24868
NMEC 7 311 197 171,252 5.20 50.63 58893
NMEC 8 160 52 531,258 4.92 50.55 177127
NMEC 11 305 193 250,823 5.21 50.6 57634
NMEC 14 244 137 284,584 5.05 50.66 117543
NMEC 15 247 105 418,432 5.23 50.56 154846
NMEC 16 137 64 516,108 4.93 50.56 171565
NMEC 18 171 62 703,355 5.08 50.57 322711
NMEC 19 147 76 401,764 4.91 50.61 139554
NMEC 20 178 76 457,407 5.01 50.62 172171
NMEC 22 168 73 812,195 5.22 50.71 196545
NMEC 23 450 216 292,119 5.26 50.53 74570
NMEC 26 199 81 612,860 5.05 50.56 173783
NMEC 27 352 192 266,060 5.05 50.68 89766
NMEC 28 194 92 432,717 5.18 50.7 170238
NMEC 29 210 77 421,341 5.21 50.66 266902
NMEC 30 282 96 440,598 5.22 50.66 191667
NMEC 34 421 233 247,335 5.14 50.58 44186
NMEC 35 410 171 231,118 5.13 50.6 84412
NMEC 36 216 100 451,924 5.16 50.52 186035
NMEC 37 287 108 552,239 5.17 50.55 173395
NMEC 38 270 129 434,159 5.22 50.56 114966
NMEC 40 127 67 433,073 5.08 50.41 168383
NMEC 42 194 94 349,405 5.12 50.36 80856
NMEC 43 179 90 702,431 5.17 50.57 173442
NMEC 45 180 199 283,798 4.99 50.65 92111
NMEC 49 133 62 397,745 4.95 50.51 182434
NMEC 52 117 52 546,582 5.03 50.62 190962
NMEC 55 181 105 364,933 5.10 50.73 149429
NMEC 57 157 68 455,812 4.93 50.55 169504
NMEC 59 163 83 578,758 4.98 50.55 213151
NMEC 60 114 55 681,191 5.27 50.6 195201
NMEC 65 117 55 516,850 4.94 50.58 211094
NMEC 67 110 54 658,344 4.93 50.57 231496
NMEC 70 239 90 419,133 5.16 50.59 203905
NMEC 71 125 57 444,515 4.88 50.6 253886
NMEC 72 169 76 444,419 5.03 50.53 175273
NMEC 73 177 96 219,994 4.74 50.82 123827
NMEC 74 425 230 214,651 5.42 50.54 63216
NMEC 81 237 98 368,051 5.13 50.34 156132
NMEC 82 216 85 453,216 5.16 50.52 203913
NMEC 83 407 235 214,378 5.23 50.6 47944
NMEC 84 85 34 585,631 4.84 50.53 343102
NMEC 86 960 504 73,433 5.14 51.15 18407
NMEC 89 247 97 577,928 5.13 50.65 203906
NMEC 91 284 157 285,197 5.26 50.51 112369
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Virulence Genotyping.  To assess the virulome of NMEC, all sequenced NMEC, 
selected ExPEC, and laboratory E. coli strains were assessed for their content of 
virulence genes using using MvirDB available through the Lawrence Livermore National 
Laboratory (55) using an all-versus-all nucleotide BLAST (56).  A Perl script was used to 
remove low quality blast hits, removing hits where the subject sequence was less than 
95% of the query sequence’s length, below 95% sequence identity, or expected value was 
above 1.0 e-20.  Resultant BLAST hits were examined manually to remove duplicate 
gene entries. 
Antimicrobial Resistance Genotyping.  Antimicrobial resistance profiles for 
sequenced genomes were determined by comparison to the Comprehensive Antibiotic 
Resistance Database (CARD) (57).  Nucleotide sequences for antimicrobial resistance 
were compared to a database of assembled NMEC sequences using default parameters.  
A Perl script was used to filter the resultant gene list.  Hits where the subject sequence 
was less than 95% of the query length, 95%  sequence identity, or expected value above 
1.0 e-20 were removed from the analysis. 
Antimicrobial Susceptibility Phenotyping.  Antimicrobial susceptibility of the 
NMEC isolates used in this study was determined using the broth microdilution method 
and the National Antimicrobial Resistance Monitoring Scheme (NARMS) (58) 
(Sensititre, Trek Diagnostics, Cleveland, OH) according to the Clinical Laboratory 
Standards Institute.  NMEC strains were tested for succeptibility to the following 
antimicrobials:  amikacin (0.5 - 64 μg/ml), ampicillin (1 - 32 μg/ml), 
amoxicillin/clavulanic acid (1/0.5 - 32/16 μg/ml), ceftriaxone (0.25 - 64 μg/ml), 
chloramphenicol (2 - 32 μg/ml), ciprofloxacin (0.015 - 4 μg/ml), 
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trimethoprim/sulfamethoxazole (0.12/2.38 - 4/76 μg/ml), cefoxitin (0.5 - 32 μg/ml), 
gentamicin (0.25 - 16 μg/ml), kanamycin (8 - 64 μg/ml), nalidixic acid (0.5 - 32 μg/ml), 
sulfisoxazole (15-256 μg/ml), streptomycin (32 - 64 μg/ml), tetracycline (4 - 32 μg/ml), 
and ceftiofur (0.12 - 8 μg/ml).  Resistance and susceptibility cutoffs were determined 
using CLSI interpretive criteria as follows: Amikacin (≥ 64 μg/ml), ampicillin (≥ 32 
μg/ml), amoxicillin/clavulanic acid (≥ 32/16 μg/ml), ceftriaxone (≥ 4 μg/ml), 
chloramphenicol (≥ 32 μg/ml), ciprofloxacin (≥ 4 μg/ml), trimethoprim/ 
sulfamethoxazole (≥ 4/76 μg/ml), cefoxitin (≥ 32 μg/ml), gentamicin (≥ 16 μg/ml), 
kanamycin (≥ 64 μg/ml), nalidixic acid (≥ 32 μg/ml), sulfisoxazole (≥ 512 μg/ml), 
streptomycin (≥ 64 μg/ml), tetracycline (≥ 16 μg/ml), and ceftiofur (≥ 8 μg/ml). 
ompA and fimH polymorphism analyses.  Nucleotide sequences for the ExPEC 
virulence genes fimH and ompA were extracted from the genome of NMEC strain S88 
and queried against a BLAST database of assembled genomes.  A BLAST hit cutoff, 
excluding hits with an overlap length and total identities of less than 90%, was used to 
remove erroneous fragments from the analysis.  Sequences were concatenated and 
aligned using ClustalOmega using default parameters (59).  The resulting alignment was 
used to generate a phylogeny using FastTree2, options for GTR+CAT model and gamma 
distributed rate variation.  The nucleotide sequences were then translated into protein 
sequences and aligned to their known structures to compare amino acid changes within 
protein active sites. 
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Results 
NMEC and ExPEC Core Genome Phylogenies Show Distinct NMEC Lineages.   
A total of 48 NMEC strains, isolated from different patients with neonatal 
bacterial meningitis in the United States and the Netherlands representing phylogenetic 
groups A, B1, B2, C, D, E, and F were selected for genome sequencing.  Strains 
sequenced were also highly divergent in terms of serogroup, but a significant number of 
O18, O83 and untypeable serogroups were found among the sequenced group. To 
determine the relatedness of NMEC strains to each other and other E. coli and to 
elucidate their evolutionary history, SNPs from strains sequenced in this study and all 
previous publically available NMEC genomes were combined with representative strains 
from other ExPEC sub-pathotypes APEC and UPEC as well as non-pathogenic 
laboratory strains W3110 and DH1, (Figures 1 and 2). The core shared genome of ExPEC 
and laboratory strains in this study was 2.2Mbp. The SNP-based phylogenies revealed 
large evolutionary differences among all of the NMEC strains examined, but close 
relationships were observed between many of the NMEC based on where they clustered.  
Lab strains, E. coli W3110 and DH1, formed a new distinct node when added.  The three 
APEC strains examined, APEC O1 and O78, did not form a single node but clustered 
within nodes containing NMEC strains.  Uropathogenic Escherichia coli (UPEC) strains 
UTI89 and CFT073 clustered into separate nodes.  These distinct clustered nodes and 
sister nodes contained NMEC strains and indicate, on a whole genomic level, a closer 
relationship of these APEC and UPEC strains to NMEC than each other.   
Segregation of taxa within the SNP phylogeny suggests strong association 
between strains based on serogroup.  The predominant NMEC serogroup, O18, were all 
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of the B2 phylogenetic group and clustered into closely related sister nodes, along with 
APEC O18, CFT073, and UTI89.  Similarly, five of the six O83 strains, all assigned to 
phylogenetic group B2, clustered together in closely related sister nodes distinct from the 
O18 serogroups.  Serogroups O21 and O45 were also closely clustered in the SNP 
phylogeny, but the limited number of sequenced samples limits inference of the 
similarities of O21 and O45 strain.  Serogroups O1, O6, O7, O12, O14 and untypeable 
strains, regardless of sub-pathotype, did not form independent nodes, and were 
interspersed throughout the phylogeny.  Strain phylogenetic type also showed an apparent 
correlation with the SNP derived phylogenetic landscape.  As evolutionary distance from 
laboratory strains increased in the SNP phylogeny, the strains of the same clermont 
phylogenetic type clustered into nodes or sister nodes following a progression (A-(C or 
B1) EDFB2) similar to previous study (50), and the predominant strains in the 
latter portion, B2, D, and F, coincides with studies implicating these strains more 
commonly in human disease (60).  Correlations of genome size between phylogenetic 
branches or serogroup were not performed, as the presence of plasmid DNA in the strains 
sequenced in this study as well as the incomplete assembly of the sequenced reduces the 
value of such comparisons. The phylogeny was also assessed for the relationship between 
country of isolation and phylogenetic relationship.  There was no readily apparent pattern 
of segregation by country of origin in the phylogeny. 
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Figure 1.  Whole genome maximum likelihood hylogeny of previously sequenced, and NMEC strains sequenced in this study, through single nucleotide 
variant concatenation and alignment.  Whole genomes or assembled contigs aligned using the Muscle algorithm in Harvest Genomic Tools Parsnp version 1.2.  
The phylogeny was generating using FastTree2 and visualized using FigTree v1.4.2.  Colored taxa represent Clermont expanded phylogenetic groups:  Black A, 
Maroon C, Orange, B1, Gold E, Cyan D, Green F, and Red B2.
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Figure 2.  Whole genome maximum likelihood phylogeny of previously ExPEC strains and NMEC strains in this study.  Single nucleotide polymorphism 
variants concatenation and alignment.  Whole genomes or assembled contigs aligned using the Muscle algorithm in Harvest Genomic Tools Parsnp version 1.2.  
The phylogeny was generating using FastTree2 and visualized using FigTree v1.4.2.  Each strain’s O-serotype follows the taxa label.  Colored taxa represent 
Clermont expanded phylogenetic groups:  Dark Blue A, Maroon C, Orange, B1, Gold E, Cyan D, Green F, and Red B2
6
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Virulence factor database screening.  
 Assembled NMEC sequences as well as additional ExPEC and laboratory E. coli 
strains were assessed using the Lawrence Livermore National Laboratory LLNL 
virulence database and nucleotide BLAST for putative virulence factors.  Initial results 
identified 4,875 potential virulence genes among all of the genomes examined.  After 
removing entries with identical distribution, gene length, and gene names in addition to 
manual inspection, the potential gene pool was reduced to 1,231 (61, 62).  Among them, 
only 299 genes were present in greater than 50% of ExPEC strains, and 208 genes 
including ompA are also present in E. coli K12 strains like W3110 and DH11.    
The prevalence of genes previously identified as contributors to NMEC 
pathogenesis including the genes encoding K1 capsular synthesis, kpsDMT (63, 64) 
arylsulfatase aslA (26), invasion protein ibeA (24, 65, 66), the S fimbrial switch protein 
sfaC, (66, 67), fimbrial adhesin fimH (15, 68) and outer membrane ompA (11, 69, 70) was 
determined in all ExPEC and laboratory strains in this study.   Additional virulence 
factors of ExPEC that have not been associated with NMEC before were also found in 
this pool, including the fimbrial and motility, regulating genes papX and prsX (71), the 
serine protease autotransporter protein vat (61, 62), and the hemin receptor protein chuA 
(72).  Additionally 24 genes related to iron acquisition including the yersiniabactin, 
enterobactin, and aerobactin operons, as well as the gene encoding the iron sensing 
protein fhuF (73) and metabolic genes likely to enhance siderophore production, were 
identified. 
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Genes putatively associated with two multi-drug efflux pumps, three ABC 
transporter systems, two non-ribosomal peptide synthesis systems, and a putative 
transcriptional regulator were also found in ExPEC strains but not laboratory strains. The 
remaining genes of the pool were associated with phage proteins, mobile genetic 
elements, and insertion sequences.  The full list of virulence genes, percentage incidence, 
presumed function, and individual strain incidence are reported in Table S1. 
 fimH Polymorphism Analysis Reveals Novel Polymorphic Patterns.  
FimH has been previously correlated with NMEC and UPEC pathogenesis (15, 
43, 68, 74).  Although fimH was found to be ubiquitous among the assayed strains 
whether from ExPEC or laboratory strains, previous studies showed that adhesion FimH 
was subjected to positive selection and certain site mutations have been associated with 
increased in vivo fitness. The sequences of fimH showed 95.9% nucleotide identity in the 
gene.  Conversion to amino acid sequence showed polymorphisms in 24 of the 300 
residues, corresponding to 8% of the protein in positions.  Amino acid residues 
comprising the mannose binding pocket, or mannose chaperoning residues (positions 1, 
13, 46-48, 52, 54, 133, 135, 140, and 142) contained no amino acid polymorphisms as 
found in previous studies (43, 74).  In total, 32 polymorphic amino acid sites were found 
among all strains, while 10 sites showed increased incidence of polymorphisms (Figure 
3).  UPEC FimH sites previously defined as under positive selection and enhancing 
uroepithelial cell binding (V27, S62, and V163) were examined (74).  Sequenced NMEC 
strains were compared with previously sequenced APEC strains including χ7122 (75) 
(n=4), sequenced APEC fimH genes (n=23) (76) as well as sequenced UPEC genomes 
and the Broad Institute’s Escherichia coli as a human pathogen project (n=143).   
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Table S1.  Listing of all virulence genes detected in NMEC strains sequenced.  Grid association of virulence genes incidence and the respective genomes.  Red 
indicates virulence gene positive strains, while black indicates negative strains.     
 
Gene Putative Function NM2 NM3 NM6 NM7 NM8 NM11 NM14 NM15 NM16 NM18 NM19 NM20 NM22 NM23 NM26 NM27 NM28 NM29 NM30 NM34 NM35 NM36 NM37 NM38 NM40 NM42 NM43 NM45 NM49 NM52 NM55 NM57 NM58 NM59 NM60 NM65 NM67 NM70 NM71 NM72 NM73 NM74 NM81 NM82 NM83 NM84 NM86 NM89 NM91 RS218 S88 IHE3034 CE10 W3110
mdtN Multidrug resistance protein MdtN 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 0
gspL Putative type II secretion system protein L 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0
entE 2,3-dihydroxybenzoate-AMP ligase 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
fyuA Pesticin Receptor 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
kpsD Polysialic acid transport protein KpsD 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 0
ybtE Salicyl-AMP ligase 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
ybtT Yersiniabactin biosynthetic protein YbtT 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
ybtU Yersiniabactin biosynthetic protein YbtU 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
chuA Outer membrane heme/hemoglobin receptor chuA 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0
chuT putative periplasmic binding protein 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0
hemF/chuW Oxygen-dependent coproporphyrinogen-III oxidase 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0
ybtA Yersiniabactin transcriptional regulator, YbtA 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
ybtQ Inner membrane ABC-transporter YbtQ 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
ybtX Yersiniabactin-iron transporter permease YbtX 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
aslA Arylsulfatase 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
chuS putative heme/hemoglobin transport protein 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0
chuX Putative heme utilization carrier protein ChuX 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
ybtP Lipoprotein inner membrane ABC-transporter 0 1 0 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
irp2 Yersiniabactin non-ribosomal peptide synthase 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0
irp9 salicylate synthase Irp9 0 1 0 0 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
irp1 HMWP1 nonribosomal peptide/polyketide synthase 0 1 0 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 1 1 1 1 1 0
yeeS UPF0758 protein YeeS 1 1 0 1 1 0 1 0 1 0 1 1 0 1 1 1 0 1 1 0 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0
fepG Ferric enterobactin transport system permease protein FepG 1 1 0 1 1 1 0 1 1 1 1 0 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 1 1 1 1 1 0
fhuF Ferric iron reductase protein FhuF 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 0 1 1 0 1 1 0 0 1 1 0 1 1 0
kspM Polysialic acid transport protein KpsM 1 1 0 1 1 1 0 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 0 1 1 1 1 1 1 0
iroD Ferric enterochelin esterase 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 0 1 0 1 0 1 0 0
iroE IroE, putative hydrolase 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 0 1 0 1 0 1 0 0
papX/prsX HTH-type transcriptional regulator PapX 1 1 1 0 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 0 0 1 1 1 1 1 1 0
yeeP 50S ribosome-binding GTPase family protein 1 0 1 1 1 1 0 1 1 1 1 0 1 1 1 0 1 0 1 1 0 0 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 0 1 0 0 1 0 0 1 1 1 1 1 1 0
iroC ABC transporter protein IroC 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 0 1 0 1 0 1 0 1 0 1 0 0
iucB Aerobactin biosynthesis protein IucB 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 0 1 0 1 1 1 1 0 1 1 1 0 0 0 1 0
iucC Aerobactin biosynthesis protein IucC 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 0 1 0 1 1 1 1 0 1 1 1 0 0 0 1 0
iucD Aerobactin biosynthesis protein IucD 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 0 1 0 1 1 1 1 0 1 1 1 0 0 0 1 0
kpsT Polysialic acid transport ATP-binding protein KpsT 1 1 0 1 1 1 0 1 1 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 0 1 0 0 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 0 1 1 1 1 1 1 0
emrE Multidrug transporter EmrE 1 1 0 1 0 1 0 1 0 1 0 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 0 0 1 1 1 0 0 1 1 1 0 1 1 1 0 1 0 1 0 1 1 1 0 0
iroB Glucosyltransferase 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 0 0 0 1 0 1 0 1 0 1 0 1 0 1 0 0
rusA Holliday junction nuclease RusA 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 0 1 1 1 1 0 0 0 0 1 0 1 1 1 0 0 1 1 1 0 0 0 1 0 1 0 1 1 1 1 1 1 1 1 0
- putative MarR-family transcriptional regulator 1 1 0 0 1 1 0 1 1 1 1 0 1 0 1 0 1 1 1 0 0 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 0 0 1 1 0 0
fepA Ferrienterobactin receptor 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 0 0 0 1 0 1 0 1 0 1 0 1 0 1 0 0
gspH putative type II secretion protein 1 1 0 1 0 1 1 1 0 1 0 1 1 0 1 0 1 1 1 0 0 1 1 1 1 0 0 1 0 0 0 0 1 1 1 0 0 1 1 1 1 1 1 1 0 0 0 1 0 1 1 1 0 0
- putative hemin receptor 1 1 0 1 1 1 0 1 1 1 1 0 1 1 0 1 1 0 1 1 1 0 1 1 0 1 1 0 1 0 0 1 1 1 0 1 1 0 0 0 0 1 1 0 1 0 0 0 1 0 0 1 0 0
c3581 hypothetical protein c3581, Escherichia coli CFT073 0 1 0 1 1 0 1 0 1 0 1 0 0 0 1 0 0 1 0 1 0 1 1 1 0 0 0 1 0 0 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 0 0 0
parB ParB partioning protein 1 1 0 1 1 1 0 1 1 0 1 0 0 1 1 1 0 0 1 1 1 0 0 1 0 0 0 0 1 0 1 1 0 0 0 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 0 1 1 0
ibeA invasion protein IbeA 1 1 1 1 1 1 0 1 1 1 1 0 1 0 0 0 1 0 1 0 1 0 1 1 1 1 1 0 1 1 0 1 1 0 0 1 1 0 0 0 0 0 1 0 0 1 0 0 0 1 0 1 0 0
mchE microcin H47 secretion protein 1 1 0 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 1 1 1 0 0 1 1 1 0 0 1 1 0 0 1 1 1 1 0 0 0 1 0 1 0 1 0 1 0 0 0 0 0 0
sfaC Putative F1C and S fimbrial switch regulatory protein SfaC 1 1 0 1 1 1 0 1 1 1 1 0 1 0 0 1 1 0 1 1 1 0 1 1 1 0 0 1 1 0 0 1 1 1 0 1 1 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 0
vat Vacuolating autotransporter toxin 1 0 1 0 0 1 0 1 0 1 0 0 1 0 0 0 1 1 1 0 1 1 0 0 1 1 1 0 1 0 0 0 1 1 1 1 0 1 0 0 0 0 1 1 0 1 0 1 0 1 1 1 0 0
fliC Flagellin 1 1 0 1 0 1 0 1 0 1 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 1 1 0 0 0 0 0 1 1 1 0 0 1 0 0 0 0 0 1 1 0 0 1 0 1 1 1 0 0
- hypothetical protein c5153 0 1 0 1 1 0 1 0 1 0 1 0 0 0 1 1 0 1 1 0 1 0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 0
- hypothetical protein 1 1 1 1 1 1 0 1 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 0 1 1 1 0 0
- hypothetical protein 0 0 0 1 1 0 1 1 1 1 1 0 1 1 1 0 0 1 1 0 0 1 0 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 1 0 0 0 1 0 0 1 0 1 1 1 1 1 0
- hypothetical protein c3187 0 0 0 0 1 0 0 0 1 0 1 1 0 0 0 0 0 1 0 0 1 1 0 1 0 1 1 0 1 0 1 1 1 0 1 1 1 0 0 0 0 1 0 1 1 1 0 1 1 1 1 1 1 0
- hypothetical protein 1 1 0 1 1 1 0 1 1 1 1 0 1 1 0 1 1 0 1 1 1 0 1 1 0 1 1 0 1 0 0 1 1 1 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 0
- hypothetical protein 1 1 0 1 1 1 0 1 1 1 1 0 1 0 0 0 1 1 1 0 0 1 1 1 0 0 0 0 1 0 0 1 1 1 1 1 1 1 0 0 0 0 1 0 0 0 0 1 0 1 1 1 0 0
Z Putative tail component of prophage CP-933O 1 0 1 0 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0
O partial O replication protein for prophage CP-933H 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 0 1 1 1 0 0
ECs1109 putative head decoration protein 0 1 1 0 1 1 0 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 0 1 0 0 1 1 1 1 1 1 0 1 1 0 0 1 0 0 1 1 1 1 1 1 1 1 0
- putative minor tail protein 1 1 0 1 1 1 0 1 1 1 1 0 1 0 1 1 1 1 1 0 1 1 1 1 0 0 0 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 1 1 1 1 1 1 1 0
- putative tail component of prophage 0 1 1 0 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 1 0 1 1 1 0 0 0 0 1 1 0 1 1 1 1 1 1 1 0 0 1 1 1 1 1 0 0 0 1 0 1 1 1 0
- putative minor tail protein 1 1 0 1 1 1 0 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 0 0 1 0 0 1 1 1 1 1 1 0
- putative head-tail joining protein of prophage 1 1 0 1 1 1 1 1 1 0 1 0 0 1 1 1 0 0 1 1 1 0 1 1 1 0 0 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 0 1 0 1 0 0 1 1 0
- putative head completion protein 1 1 1 0 1 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 1 1 0 1 0 0 1 1 1 0 1 1 1 1 1 0 0 1 1 0 1 0 0 1 1 1 1 1 0
- putative tail component of prophage 1 1 1 1 1 1 0 1 0 1 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 0 1 0 1 1 1 0 1 1 1 1 1 1 0
- putative head-tail joining protein of prophage 1 1 0 1 1 1 1 1 1 0 1 0 0 1 1 1 0 0 1 0 1 0 1 1 1 0 0 0 1 0 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 0 1 0 1 0 0 1 1 0
- putative DNA packaging protein of prophage 1 1 0 1 0 1 1 1 1 0 1 0 0 0 1 1 0 0 1 1 1 0 1 1 1 0 0 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1 1 0 1 0 1 0 0 1 1 0
- hypothetical protein Z1653 1 1 1 1 0 1 0 1 0 1 0 0 1 1 0 0 1 1 1 0 1 1 1 1 0 1 1 0 0 1 0 0 1 1 1 0 0 1 0 0 0 1 0 1 0 1 0 1 1 1 1 1 1 0
- putative tail component of prophage 0 1 1 1 1 0 1 0 1 0 1 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 1 1 1 0
- putative head-DNA stabilization protein of prophage 1 1 0 1 1 1 1 1 1 0 1 0 0 1 1 1 0 0 1 1 1 0 1 1 1 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 0 1 0 0
- putative capsid protein of prophage 1 1 0 1 1 1 0 1 1 0 1 0 0 0 1 1 0 0 1 0 1 0 1 1 1 0 0 0 1 0 1 1 0 0 0 1 1 1 1 1 1 1 1 1 0 0 1 0 1 0 0 1 1 0
- putative tail component of prophage 0 1 1 1 1 1 0 1 1 1 1 0 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 1 0 1 1 1 1 1 1 1 1 0 0 1 1 1 0 0 0 0 0 0 1 0 1 0 0
- putative minor tail protein 1 1 0 1 1 1 0 1 1 1 1 0 1 0 0 0 1 1 1 0 1 1 1 1 0 0 0 0 1 0 0 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 0
int bacteriophage integrase 0 1 0 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0
IS629 IS629 ORF1 0 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 1 1 1 1 0 1 0
insA DNA-binding protein InsA 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 0 1 1 1 1 1 1 1 0 1 1 0 1 1 1 0 0 0 1 1 1 0 0 1 0
insA truncated InsA protein 1 1 1 1 1 1 0 1 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 0 1 1 1 0 0
insB truncated InsB protein 1 1 1 1 1 1 0 1 1 1 1 0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 0 1 0 1 1 1 0 0
tnp IS629 ORF1 IS3 family transposase fragment 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 1 1 0 1 1 1 1 1 0 1 0 1 1 1 1 0 1 1 1 0 0 0 1 0
IS629 transposase IS629 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 0 0 1 1 1 1 0 0 0 1 0 1 1 1 1 1 1 1 1 0 1 0 1 1 1 0 0 1 1 1 0 1 0 1 0
IS629 hypothetical protein c3596 0 1 0 1 1 1 1 0 0 1 0 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 1 1 0 1 0 1 0
insE putative transposase 0 1 0 1 1 1 0 0 0 1 0 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 1 1 0 1 0 1 0
- putative transposase 0 1 0 1 1 1 0 0 1 1 1 0 1 1 0 1 1 1 1 0 0 1 0 1 1 0 0 0 1 0 0 1 0 1 1 1 1 1 0 1 0 1 1 1 0 0 1 1 1 1 1 0 1 0
IS629 transposase IS629 1 1 0 1 1 1 0 1 1 1 1 0 1 1 0 0 1 1 1 0 0 1 1 1 1 0 0 0 1 0 1 1 1 1 1 1 1 1 0 0 0 1 1 1 0 0 1 1 1 0 1 0 1 0
- putative transposase 0 1 0 1 1 1 0 1 1 1 1 0 1 1 0 0 1 1 1 0 0 1 0 1 1 0 0 0 1 0 0 1 0 1 1 1 1 1 0 1 0 1 1 1 0 0 1 1 0 1 1 0 1 0
- hypothetical transposase 0 1 0 1 1 1 0 0 0 1 0 1 1 0 1 0 1 1 1 0 1 1 0 1 1 0 0 1 1 0 1 1 0 1 1 1 1 0 1 1 0 1 1 1 0 0 0 1 1 1 0 0 1 0
IS629 IS629 ORF2 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 0 0 1 1 1 1 0 0 0 1 0 1 1 1 0 1 1 1 1 0 0 0 1 0 1 0 0 1 1 1 0 0 0 1 0
IS629 transposase IS629 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 0 0 1 1 1 1 0 0 0 1 0 1 1 1 0 1 1 1 0 0 0 0 1 0 1 0 0 1 1 1 0 0 0 1 0
IS629 IS629 ORF2 1 1 0 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 1 0 1 1 0 1 1 0 0 0 1 0 0 1 0 0 1 1 1 0 0 0 0 1 0 1 0 0 1 1 0 0 0 0 1 0
orfA ORF A protein 1 1 1 1 0 1 1 1 0 1 0 0 1 1 0 0 1 0 1 1 0 0 1 1 0 1 1 1 0 1 0 0 1 0 1 0 0 1 0 0 1 0 1 0 1 1 0 0 1 0 0 1 1 0
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Total NMEC UPEC APEC
ASV 154 47 81 26
ASA 1 0 1 0 CFT073
AAV 3 2 1 0 UTI89
VAA 0 0 0 0
AAA 0 0 0 0
VSV 73 4 65 1 K12
Total 231 53 148 27
Total NMEC UPEC APEC
ASV 66.7% 88.7% 54.7% 96.3%
ASA 0.4% 0.0% 0.7% 0.0% CFT073
AAV 1.3% 3.8% 0.7% 0.0% UTI89
VAA 0.0% 0.0% 0.0% 0.0%
AAA 0.0% 0.0% 0.0% 0.0%
VSV 31.6% 7.5% 43.9% 3.7% K12
 Figure 3.  Amino acid alignment of variable amino acid residues in FimH.  Alignment of the 10 most 
variable amino acid residues among all ExPEC in this study.  Fisher’s exact test to compare amino 
frequencies among pathotypes. *** p< 0.0001:   ** p< 0.005:   * p< 0.01 
 
Using this three-polymorphism system, 89% of NMEC, 55% of UPEC, and 96% of 
APEC were classified as A27 S62 V163.  The remaining 44% of UPEC strains possessed 
27V 62S 163V polymorphism patterns, as seen in K12 E. coli strains (Table 3).  This 
same set of genomes were compared to adherent-invasive E. coli in 10 mutational 
hotspots (43). The resulting distribution shows separation beginnings of separation 
between APEC, NMEC, and UPEC strains, but the large number residues examined 
creates numerous polymorphic patterns present in only one or two strains (Table 4). 
 
 
Table 4.  FimH alleles based on adherent- 
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Table 4.  FimH alleles based on adherent-invasive E. coli 
 
Identification of the most common amino acid residues at each polymorphic site 
and its incidence was performed for all strains, and results were grouped by sub-
pathotype (Table 5).   The resulting analysis showed four sites (positions 27, 70, 78 and 
119) with significantly different prevalence of mutations between at least two sub-
pathotypes.  Concatenation of these polymorphic sites resulted in 5 distinct FimH 
polymorphic patterns, with the most prevalent patterns being: ASNA in NMEC (52.8%), 
VSNA in UPEC (53.9%), and ANSA in APEC (66.7%), all of which were significantly 
more prevalent in their respective sub-pathotype at P < 0.01 as determined by Fisher’s 
exact test. 
 
Total NMEC UPEC APEC Total NMEC UPEC APEC
TVGNGATVRY 78 4 65 1 K12 TVGNGATVRY 28.5% 7.5% 43.9% 3.7% K12
TAGNGATVRY 64 5 31 20 TAGNGATVRY 23.4% 9.4% 20.9% 74.1%
NAGNGATVRY 40 5 25 0 NAGNGATVRY 14.6% 9.4% 16.9% 0.0%
TAGSGATVRY 26 16 3 5 UTI89 TAGSGATVRY 9.5% 30.2% 2.0% 18.5% UTI89
TAGNGATVHY 19 3 15 1 TAGNGATVHY 6.9% 5.7% 10.1% 3.7%
TACNGATVRY 7 3 3 0 TACNGATVRY 2.6% 5.7% 2.0% 0.0%
TAGSGVTVSY 6 6 0 0 TAGSGVTVSY 2.2% 11.3% 0.0% 0.0%
TASSGATVRY 4 3 1 0 TASSGATVRY 1.5% 5.7% 0.7% 0.0%
TAGNGATVHH 3 0 0 0 TAGNGATVHH 1.1% 0.0% 0.0% 0.0%
TAGNGATVRF 3 2 0 0 TAGNGATVRF 1.1% 3.8% 0.0% 0.0%
TASNGATVRY 3 0 3 0 TASNGATVRY 1.1% 0.0% 2.0% 0.0%
TADNGATVRY 2 1 1 0 TADNGATVRY 0.7% 1.9% 0.7% 0.0%
TAGNAATVRY 2 0 0 0 TAGNAATVRY 0.7% 0.0% 0.0% 0.0%
TAGNWATVRY 2 0 0 0 TAGNWATVRY 0.7% 0.0% 0.0% 0.0%
TAGSGATARY 2 0 1 0 CFT073 TAGSGATARY 0.7% 0.0% 0.7% 0.0% CFT073
NAGNGATVRF 1 1 0 0 NAGNGATVRF 0.4% 1.9% 0.0% 0.0%
PAGNGATVRY 1 1 0 0 PAGNGATVRY 0.4% 1.9% 0.0% 0.0%
PAGSGVTVSY 1 1 0 0 PAGSGVTVSY 0.4% 1.9% 0.0% 0.0%
SAGSGATVRY 1 1 0 0 SAGSGATVRY 0.4% 1.9% 0.0% 0.0%
TAASGTTVRY 1 0 0 0 TAASGTTVRY 0.4% 0.0% 0.0% 0.0%
TAGNGATVCC 1 0 0 0 TAGNGATVCC 0.4% 0.0% 0.0% 0.0%
TAGNGATVSY 1 0 0 0 TAGNGATVSY 0.4% 0.0% 0.0% 0.0%
TAGSEATVRY 1 0 0 0 TAGSEATVRY 0.4% 0.0% 0.0% 0.0%
TAGSGAAVRY 1 0 0 0 TAGSGAAVRY 0.4% 0.0% 0.0% 0.0%
TAGSGAPVRY 1 0 0 0 TAGSGAPVRY 0.4% 0.0% 0.0% 0.0%
TAGSGVTVRY 1 1 0 0 TAGSGVTVRY 0.4% 1.9% 0.0% 0.0%
TAGSRATVRY 1 0 0 0 TAGSRATVRY 0.4% 0.0% 0.0% 0.0%
TAGSWATVRY 1 0 0 0 TAGSWATVRY 0.4% 0.0% 0.0% 0.0%
Sum 274 53 148 27
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Table 5.  FimH allele analysis based on residue variance in positions 27, 70, 78, and 119 
 
 
Sequenced ompA of NMEC display 7 unique patterns of polymorphisms, while OmpA of 
UPEC is relatively conserved.  
The sequences of the outer membrane protein gene ompA were extracted from the 
assembled genomic sequences of NMEC, ExPEC, and the laboratory strains.  The 
extracted 1056 bp nucleotide sequences contained nucleotide polymorphisms or gaps in 
91 positions (8.6%).  Transmembrane loops and periplasmic turns were identified in all 
ExPEC and laboratory sequences used in this study.  Resulting concatenation of protein 
polymorphic sites resulted in 7 distinct OmpA polymorphic alleles differing at 16 
residues (Figure 4).  Some OmpA alleles differ by as little as one amino acid, while other 
alleles differ in all 16 amino acid positions.  The most frequently occurring polymorphic 
sites in NMEC when compared to UPEC were in loop positions 1-3.  These 
polymorphisms frequently altered hydrophobicity or charge of the extracellular loop 
residues.  Loop 3 polymorphisms often included a 5 amino acid insertion, increasing the 
Total NMEC UPEC APEC X2
VNSA 78 4 65 1 K12 P< 0.0001
ASNA 47 28 5 5 CFT073 UTI89 P< 0.01
ANNA 12 4 0 3 P< 0.05
ANSA 97 12 53 18
ANSV 39 5 24 0
Sum 273 53 147 27
Total NMEC UPEC APEC
VNSA 28.6% 7.5% 44.2% 3.7% K12
ASNA 17.2% 52.8% 3.4% 18.5% CFT073 UTI89
ANNA 4.4% 7.5% 0.0% 11.1%
ANSA 35.5% 22.6% 36.1% 66.7%
ANSV 14.3% 9.4% 16.3% 0.0%
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Extracellular Loop L1 L4
AA Position 46 87 88 89 114 129 131 132 133 134 135 136 137 138 140 177 187 201 229 277
MG1655 N S V E I S V - - - - - Y G N H M A N G
NMEC N S V E V S V - - - - - Y G N H M A T A
0.566038 0.641509 0.641509 0.641509 0.679245 0.622642 0.566038 0.622642 0.622642 0.622642 0.622642 0.622642 0.566038 0.622642 0.641509 0.962264 0.943396 0.962264 0.867925 0.811321
UPEC N S V E V S V - - - - - Y G N H M A T G
0.992248 0.992248 0.992248 0.976744 0.72093 0.992248 0.976744 0.992248 0.992248 0.992248 0.992248 0.992248 0.976744 0.992248 0.992248 1 1 0.992248 0.728682 0.534884
L2 L3 C-terminal
  
 
 
Figure 4. Amino acid alignment of variable amino acid residues of OmpA. 
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loop size to 9 amino acids.  Polymorphisms of UPEC were primarily found in the C 
terminal end of the protein, and were not contained in the extracellular loops used for 
OmpA typing in this study.  UPEC most often possessed the OmpA allele 1 from this 
study, with only 5 strains (3.4%) possessing a different polymorphic pattern, and are 
strikingly different from NMEC, where 48.1% of strains carried a different allele.   When 
examining the polymorphisms in the C-terminal protein portion, polymorphisms occurred 
more frequently in UPEC strains (54.3%) versus NMEC strains (24.5%), but little no 
studies have been performed regarding the function of this region in NMEC or UPEC 
virulence.   
Antibiotic Resistance Genotyping.    
Assembled NMEC strains (48), previously assembled NMEC strains (5) as well 
as UPEC (2) and APEC (3) genomes were assessed using BLAST and the CARD 
antimicrobial resistance database to identify antimicrobial resistance genes.  The resultant 
analysis identified 481 possible antimicrobial resistance-associated genes amongst all of 
the assembled NMEC isolates.  Scripts were used to assess the pool of 481 candidate 
genes for duplications. A majority of duplicated or repeated resistance genes resulted 
from polymorphisms occurring within similar resistance genes, notably blaTEM, 
encoding resistance to extended spectrum beta-lactamases; sul1, encoding resistance to 
sulfonamides;  and aadA conferring resistance to aminoglycosides. Such duplicates were 
removed from further consideration.  The resulting ‘de-duplicated’ resistance gene pool 
contained 22 genes encoding specific antibiotic resistances, while 45 putative non-
specific genes were identified, encoding efflux systems or genetic regulatory elements 
(Table 6).  Resulting resistance profiles revealed the most frequent antimicrobial 
1 
  
Table 6.  Heatmap listing of all antimicrobial resistance genes.  Grid map of all antimicrobial resistance genes associated with NMEC genomes. Red indicates 
positive resistance genotype; black indicates susceptible genotype.  
Gene Antibiotic NM3 NM11 NM14 NM15 NM19 NM20 NM22 NM23 NM26 NM27 NM28 NM34 NM38 NM40 NM49 NM55 NM57 NM67 NM70 NM74 NM86 NM89 NM91
bacA Bacitracin 0 0 1 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0 1 0 1
strA Streptomycin 1 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 1 1 0 1 1 1 0
sul2 Sulfonamides 1 0 0 0 1 0 0 0 0 0 1 0 1 1 1 0 1 1 0 1 0 1 0
VC Aminoglycoside 1 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 1 1 0 1 1 1 0
aadA Streptomycin, Spectomycin 1 1 0 1 0 1 1 0 1 1 0 0 0 1 0 1 0 0 1 0 0 0 0
strB Streptomycin 0 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 1 1 0 1 1 1 0
TEM-1 Beta lactam 1 0 0 0 0 1 0 0 1 0 1 1 0 1 0 1 0 0 1 0 1 1 0
aadA15 Streptomycin, Spectomycin 1 1 0 1 0 1 1 0 1 0 0 0 0 1 0 1 0 0 1 0 0 0 0
aadA22 Streptomycin, Spectomycin 1 1 0 1 0 1 1 0 0 1 0 0 0 1 0 1 0 0 1 0 0 0 0
sulI Sulfonamides 0 1 0 1 0 1 1 0 1 0 0 0 0 1 0 1 0 0 1 0 0 0 0
aadA3 Aminoglycoside 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
aadA39 Streptomycin 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
dfrA1 Trimethoprim 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0
CatA1 Chloramphenicol 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0
aadA16 Streptomycin, Spectomycin 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
aphA1 Kanamycin, Amikacin 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
mphA Macrolide 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
mphB Macrolide 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
sat Streptothricin 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
tetA Tetracycline 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
tetD Tetracycline 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
dfrA12 Trimethoprim 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7
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resistances were for aminoglycoside antimicrobials, with strains often possessing 
multiple aminoglycoside adenylyltransferases and phosphotransferase.  Profiles for 
sulfonamide resistance were similar, with a number of strains possessing plasmid borne 
sul2 (22%) or integron based sul1 (16%) (77), with a single strain, NMEC 40, possessing 
copies of both genes.  Lower frequencies of occurrence were observed for genes 
encoding resistance to phenicols and tetracyclines (<5%).  Resulting non-specific 
resistances were encoded by regulatory proteins, such as HNS and emrAB or non-specific 
efflux pumps. 
To verify the genotyping of the NMEC strains, we performed phenotypic testing 
on the NMEC strains sequenced in this study. Totaled, 27 of the sequenced NMEC 
strains harbored 65 resistance phenotypes, compared with the genotypic analysis 
predicting 113 putative resistance genes conferring resistance in 22 sequenced genomes.  
Five of the sequenced genomes, NMEC 58, 59 and 82-84, showed phenotypic 
antimicrobial resistance, but the genotypic analysis failed to identify genes known to 
grant resistance (Table 7). 
Inconsistencies between observed genotype and phenotype occurred in 19 genomes.  
Genotypic testing predicted aminoglycoside resistance in six NMEC strains and 
sulfonamide resistance in one separate strain where none was observed phenotypically. In 
addition, genotyping failed to identify tetracycline resistance in seven strains, 
aminoglycoside resistance in four strains, and beta-lactamase resistance to ampicillin in 2  
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Table 7.  NARMS antimicrobial resistance patterns for sequenced neonatal bacterial meningitis strains 
and comparison with observed antibiotic genotypes.  Comparison of observed phenotypic antimicrobial 
resistance by broth microdilution and predicted antimicrobial resistance genotypes.  Alpha error 
corresponds to a genotypically positive, but phenotypically negative result (false positive) while beta error 
refers to a genotypically negative phenotypically positive result (false negative). 
 
Strain ε
Aminoglycoside VC α
Ampicillin blaTEM
Streptomycin strA
Sulf isoxazole sul
Co-Trimoxazole dfrA
Streptomycin aadA α
Sulfisoxazole sul
Streptomycin aadA α
Sulfisoxazole sul
Aminoglycoside VC α
Streptomycin strA strB
Sulf isoxazole sul
Ampicillin blaTEM
Streptomycin aadA α
Sulfisoxazole sul
Tetracycline - β
Streptomycin aadA α
Sulfisoxazole sul
Tetracycline -
Ampicillin blaTEM
Kanamycin - β
Macrolide mphA
Streptomycin aadA α
Sulfisoxazole sul
Tetracycline - β
Co-Trimoxazole dfrA
Bacitracin bacA
Streptomycin aadA
Streptothrycin sat
Co-Trimoxazole dfrA α
Aminoglycoside VC α
Ampicillin blaTEM
Streptomycin strA strB
Sulf isoxazole sul
Tetracycline - β
NMEC 34 Ampicillin blaTEM
NMEC 38 Sulfisoxazole sul α
Aminoglycoside VC α
Ampicillin blaTEM
Chloramphenicol catA1
Macrolide mphB
Streptomycin strA strB aadA
Sulf isoxazole sul
Tetracycline - β
Co-Trimoxazole dfrA
Aminoglycoside VC α
Bacitracin bacA
Streptomycin strA strB
Sulf isoxazole sul
Tetracycline - β
Aminoglycoside VC α
Streptomycin strA strB
Sulf isoxazole sul
Ampicillin blaTEM
Bacitracin bacA
Streptomycin aadA
Sulf isoxazole sul
Tetracycline - β
Co-Trimoxazole dfrA
Aminoglycoside VC α
Streptomycin strA strB
Sulf isoxazole sul
Co-Amoxiclav - β
Ampicillin - β
Co-Amoxiclav - β
Ampicillin - β
Aminoglycoside VC α
Streptomycin strA strB
Sulf isoxazole sul
Ampicillin blaTEM
Chloramphenicol CatA1
Streptomycin aadA
Sulf isoxazole sul
Aminoglycoside VC
Kanamycin aphA1
Streptomycin strA strB
Sulf isoxazole sul
Tetracycline tetA tetD
NMEC 82 Streptomycin - β
NMEC 83 Streptomycin - β
NMEC 84 Streptomycin - β
Aminoglycoside VC α
Ampicillin blaTEM
Bacitracin bacA
Streptomycin strA strB
Tetracycline - β
Aminoglycoside VC α
Ampicillin blaTEM
Streptomycin strA strB
Sulf isoxazole sul
Co-Trimoxazole
Bacitracin bacA
Streptomycin - β
NMEC 91
Putative Resistance GenesNARMS Resistance Phenotype
NMEC 11
NMEC 15
NMEC 27
NMEC 26
NMEC 74
NMEC 59
NMEC 67
NMEC 70
NMEC 89
NMEC 86
NMEC 40
NMEC 45
NMEC 49
NMEC 55
NMEC 57
NMEC 58
NMEC 3
NMEC 19
NMEC 20
NMEC 22
NMEC 28
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strains and amoxicillin/clavulanic acid in two other strains that was detected 
phenotypically (Table 8).  Resistance gene occurrence without the corresponding 
phenotype can be explained by mutations rendering the gene ineffective, non-expression 
of the antimicrobial resistance gene in the assay, or a resistance gene conferring 
resistance to a specific antimicrobial not tested. Strains possessing an antimicrobial 
resistance phenotype without a corresponding genotype could occur for multiple reasons, 
such as a novel resistance gene not facilitating resistance or activity of efflux systems not 
currently characterized to export antimicrobials or general export systems.  Finally a 
resistance gene could be present in these strains, but located in an unassembled 
chromosomal or plasmid region. 
Table 8.  Overall incidence of genotypic and phenotypic antimicrobial resistance 
 
 
Discussion 
Current knowledge on the pathogenesis of NMEC reflects decades of research on 
the phenotypic and genetic properties of a select group of NMEC strains, namely those 
sharing the O18:K1:H7 serotype and in the B2 phylogenetic group.  In particular, much 
of what we know is owed to intensive study of a single strain of NMEC, NMEC RS218 
(20, 24, 26-29, 69, 78). While a great deal has been discovered studying NMEC RS218, it 
Antibiotic Phenotype Total Percent Antibiotic Genotype Total Percent Antimicrobial
Amikacin 0 0% Streptomycin
Co-Amoxiclav 2 4% Spectomycin
Ampicillin 12 24% aphA1 1 2% Kanamycin
Cefoxitin 0 0% bacA 5 10% Bacitracin
Ceftiofur 0 0% blaTEM 10 20% β-lactam
Ceftriaxone 0 0% catA1 2 4% Chloramphenicol
Chloramphenicol 2 4% dfrA 5 10% Co-Trimoxazole
Ciprofloxacin 0 0% mphA 1 2% Erythromycin
Gentamicin 0 0% mphB 1 2% Macrolide
Kanamycin 2 4% sat 1 2% Streptothrycin
Nalidixic Acid 0 0% strA 1 2% Streptomycin
Streptomycin 16 33% strAB 10 20% Streptomycin
Sulfisoxazole 17 35% sul 18 37% Sulfonamide
Tetracycline 9 18% tetAD 1 2% Tetracycline
Co-Trimoxazole 5 10% VC 11 22% Aminoglycoside
aadA 9 18%
Phenotype Genotype
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has become clear that it does not represent all NMEC strains (30, 31). Compounding this 
narrow focus is the paucity of diverse NMEC genomic sequences available in the public 
domain, as such sequences are often critical reagents supporting state-of-the-art 
approaches to pathogenesis studies. A number of NMEC described in the literature are 
assigned to different serotypes and phylogenetic groups than RS218 (30, 32, 33), lack K1 
capsule, and harbor diverse sets of virulence genes, including several genes thought to be 
critical to NMEC pathogenesis, such as ibeA, gimB, cnf1, and aslA (22, 23, 26, 78).  
Currently, sequenced NMEC include NMEC RS218 and IHE 3034, both of the O18:K1 
serotype (46). Though there have been efforts to expand the sequenced NMEC strains to 
better reflect this diversity (NMEC CE10 (33) and NMEC S88 (32)), relatively few 
pathogenesis studies have been carried out using these strains. As part of our purpose 
here, we seek to ascertain the diversity of NMEC, generate new genomic sequences to 
support community-wide study of diverse NMEC determine the prevalence of known 
essential virulence mechanisms, and determine if whole genome and polymorphic 
methods can distinguish between ExPEC sub-pathotypes.   
To fulfill this purpose, we sequenced 48 randomly selected NMEC strains that 
were isolated from human infants with meningitis in the United States and Europe, and 
used a genomic epidemiological approach to better characterize the NMEC sub-
pathotype.  In this manner we further enhanced the body of genomic data available for 
researchers to study in meningitis-causing E. coli, gain greater understanding of the 
disease as a whole, and glean insight into NMEC’s relationship to other ExPEC. 
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Incidence of NMEC virulence factors in sequenced strains.   
Numerous studies have characterized NMEC virulence factors (2).  These include 
cnf1, ompA, fimH, ibeA, aslA, and K1 capsular synthesis genes, all of which have been 
shown to contribute to NMEC pathogenesis (8, 39, 68, 78-81).  For instance, OmpA 
changes the secretion pattern of cytokines in macrophage and dendritic cells, facilitates 
binding to macrophage and HBMEC, and prevents classical complement activation by 
promoting degradation of complement factors C3b and C4b (13).  The K1 capsule 
contributes to invasion and resistance to the innate immune response (13).  All of these 
genes are described as significant contributors to virulence or are considered to be 
essential for NMEC pathogenesis.  Thus, it would seem that these genes would occur 
among all or most NMEC and, perhaps, few or no laboratory strains of E. coli.  This was 
not the case.   
cnf1 was found in only 3 NMEC strains sequenced in this study (NMECs 40, 42, 
45) as well as RS218, displaying a prevalence similar to previous studies (30, 31).  
Current literature suggests cnf1 facilitates invasion of the blood-brain barrier by myosin 
rearrangement facilitated by RhoGTPases (2, 78, 82, 83), but the lack of cnf1 in the 
majority of strains sequenced in this study suggests that alternate mechanisms of BBB 
transversal are more commonly utilized.  Additionally the S-fimbrial gene, sfaS, which 
encodes an adhesin shown previously to adhere to brain glycolipids and reduce 
phagocytosis (25, 84), was present in only 39.6% of sequenced NMEC strains.  ibeA, 
thought to be critical in invasion of the blood brain barrier (22, 23) was found in only 27 
NMEC isolates sequenced in this study (54.7%) as well as IHE3034 and RS218.  The 
prevalence of aslA, previously described as enhancing HBMEC invasion as well as being 
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necessary for invading HBMEC in vitro and in vivo (20, 26), and K1 capsule, which is 
thought to be critical for NMEC’s survival during HBMEC invasion (80), was high 
among sequenced NMEC was much higher (86.8% and 80% of all sequenced NMEC 
strains respectively); however, aslA was also found in APEC O1 and APEC IMT5155, 
and UPEC CFT073 and UPEC UTI89, suggesting it may play a role in pathogenicity or 
virulence of multiple ExPEC sub-pathotypes, not just NMEC.  Similarly, K1 capsule 
occurs commonly in many ExPEC as fecal flora of healthy individuals (85).  K1 capsule 
consists of a linear polymer of sialic acid, which mimics the polysialic acid located on 
human cells, and its poor immunogenicity likely functions to shield NMEC from the 
immune system (85).  In addition to these properties, K1 capsule confer resistance to 
bacteriophage infection (86), resistance to desiccation (87), and survival in serum (87, 
88). 
This study did not identify new virulence factors in NMEC strains, and confirmed 
lower prevalence of the virulence genes cnf1, ibeA, and sfaS than found in other studies 
(30).  Virulence factors most common in the NMEC population were the K1 capsule, the 
chuSTX heme utilization genes, and the putative arylsulfatase gene aslA. The K1 capsule 
is well described in NMEC (10, 85), but studies of chuSTX and aslA in NMEC are 
limited.  Sulfatases are known for involvement in cell regulation, development, and 
signaling (89).  The AslA protein may modulate these cellular process to enhance NMEC 
fitness.  Similarly chu genes are known for heme utilization and are largely thought to 
contribute to iron acquisition (72, 90), but a recent study shows chu system expression 
modulates macrophage production of IL-12 and reduces host inflammatory response (91).  
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This suggests the chu system’s role in NMEC pathogenesis may be more nuanced and 
may explain the high prevalence of this gene in the NMEC population. 
The low incidence of virulence genes and factors currently thought critical for the 
pathogenesis of NMEC, combined with some of their functional redundancy, suggests 
current knowledge of NMEC pathogenesis may be too reliant on study of few strains, and 
that pathogenesis is not fully understood.   The redundancy observed in virulence 
functions within NMEC strains indicates NMEC may utilize a “grab bag” approach, 
requiring combinations of essential genes.  This is supported by difficulties in studies 
attempting to define the NMEC sub-pathotype based on virulence gene prevalence.  One 
such study defining characteristics between NMEC and human fecal E. coli most of the 
defining characteristics separating NMEC from fecal E. coli were plasmid borne 
virulence genes such as hlyF ompTp and iss, commonly found in APEC.  A more recent 
study indicates 6 properties: kpsII (APEC 25%, UPEC 77.5%, NMEC 84.6%), K1 
capsule, neuC, iucC, sitA (AP 89.6%, UP 77%, NM 94.5%, and vat (APEC 33.6%, UPEC 
63.5%, NMEC 74.7%) can be used to define the NMEC sub-pathotype.  While these 
genes occur less frequently in other ExPEC sub-pathotypes, the gene prevalence 
differences between ExPEC sub-pathotypes are not significant (30).  Similarly, the genes 
iucC, sitA, and vat are found on large transmissible virulence plasmids.  Previous studies 
into these virulence plasmids have shown that they enhance the virulence of meningitis-
causing strains, but are not solely responsible for pathogenesis (28). Previous studies 
have cited the zoonotic potential of APEC strains and indicated some APEC may be able 
to cause disease in multiple host species and tissues due to genetic similarity (45, 92-94). 
Taken together with studies underscoring continued difficulties defining distinct ExPEC 
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sub-pathotypes (30, 31), the close evolutionary relationship of ExPEC sub-pathotypes, 
and studies showing sub-pathotypes causing disease in multiple ExPEC models (95), it is 
likely ExPEC are zoonotic pathogens.  When combined, these data show factors that 
enhance and contribute to pathogenicity, but further study regarding combinations of 
virulence factors necessary and sufficient to cause disease among the entire ExPEC sub-
pathotype are necessary. 
Polymorphism analysis of the fimH gene in comparison to UPEC and APEC. 
Previous studies of FimH, the tip adhesin of the Type 1 pilus, in UPEC (74) have 
shown that polymorphisms in amino acid residues outside of the mannose-binding pocket 
are correlated with different attachment affinities to bladder and kidney cells (74).  This 
study identified amino acid residues 27, 62, and 163 as mutational hotspots in fimH that 
impact bacterial persistence in the mouse model of chronic cystitis, identifying three 
pathogenic polymorphic patterns (74).  Based on these observations, the authors 
constructed a typing scheme.  Using this typing scheme, we found 47 of the 53 NMEC 
strains in this study (88.6%) possessed the A27/S62/V163 allele: NMEC IHE3034 and 
S88 possessed the A27/A62/V163 allele similar to UPEC UTI89: and four NMEC 
possessed the VSV allele seen in laboratory E. coli strains DH1 and W3110.  This result 
is not unexpected, as this typing scheme was originally developed to differentiate fecal E. 
coli from UPEC, and not distinguish between ExPEC sub-pathotypes (74).  According to 
work performed in UPEC strains (74), the A27/S62/V163 allele, which we found most 
commonly among NMEC, confers the ability to adhere to bladder epithelial cells but not 
as strongly as allele AAV (74). Further analysis of FimH proteins obtained from the 
Broad Institute’s E. coli as a human pathogen project show less variation at these 
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positively selected sites.   No strains from this collection possessed the enhanced bladder 
epithelial binding polymorphisms ASA or AAV found in strains CFT073 and UTI89 
respectively (74).  Instead the preponderance of UPEC strains (54.7%) showed the same 
ASV allele dominantly found in NMEC strains (88.7%), as well as a 43.9% minority 
possessing the VSV allele possessed by K12 E. coli.  These two alleles accounted for all 
UPEC strains in the study except CFT073 and UTI89.  This pattern indicated that 
polymorphisms in positions 27, 62 and 163 may not be the best discriminators of sub-
pathotypes in this study.  Analysis of all strains in this study, organized by sub-pathotype, 
instead diverged most frequently in positions 27, 70, 78, and to a lesser degree position 
119 creating 5 distinct alleles.  Fisher’s exact test showed the amino acids were 
significantly different between APEC, UPEC, and NMEC sub-pathotypes at position 70 
and 78 (P< 0.01).  In position 27 NMEC and APEC significantly differed from UPEC but 
not from each other (p< 0.0001).  Finally position 119 showed a significant difference 
between APEC and UPEC only (p< 0.01).  The VSNA allele was more common in 
UPEC strains (P< 0.0001), while NMEC possessed the ASNA allele significantly more 
often than other sub-pathotypes (P< 0.005), and finally APEC possessed the ANSA allele 
more often than both NMEC and UPEC (P< 0.01).  When taken together these data 
associate specific FimH polymorphic patterns with different ExPEC sub-pathotypes, and 
indicate the fimH gene may be under differing selection pressure in each of the sub-
pathotypes. 
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Multiple Distinct OmpA alleles are distributed across NMEC strains but not UPEC 
strains.   
OmpA is an important and multifunctional outer membrane protein in E. coli.  
OmpA has four outer membrane loops, 8 transmembrane beta strands, and three 
periplasmic turns (96).  Many of the residues in this protein are highly conserved; 
however, polymorphisms within the OmpA protein’s four outer membrane loops have 
been previously reported (97).  In addition to its role as a phage receptor, OmpA has been 
shown to contribute to many cellular processes including: adhesion, cell invasion, biofilm 
formation, ion transport, immune recognition, and immune evasion (41).  Given its 
importance in many processes in the pathogenesis of NMEC, we sought to further 
examine ompA gene for any polymorphisms that might impact NMEC virulence.  Strains 
containing the OmpA type 1 allele in this study were by far the most common, found in 
51.9% of NMEC and 96.1% of UPEC strains.  The next most common allele was 
OmpA5, present in 32.7% of NMEC strains, while absent from UPEC strains.  Indeed the 
only other alleles in UPEC strains were OmpA type 2, which differs very little from type 
1, and single isolate types 9 and 10.  This stark difference between UPEC and NMEC 
strains strongly suggests that OmpA of NMEC strains is currently is undergoing selection 
pressure.  The OmpA protein in NMEC contributes to innate immune complement 
resistance, macrophage invasion, macrophage survival, alteration of macrophage 
cytokine expression, and binding to HBMEC, and suggests these polymorphisms may 
enhance NMEC fittness.   
Current study of OmpA in NMEC strains is limited to strain RS218, carrying the 
OmpA type 1 allele (14, 98), and two studies of OmpA loop mutants in RS218 (14, 98).  
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The studies of OmpA loop mutations either deleted entire outer membrane loops (14), or 
mutated 3 to 4 consecutive outer membrane loop amino acids to alanine (98).  These 
studies showed loops 1 and 2 contributed to serum survival (14), and deletion or poly-
alanine replacements in loops 1, 2, and 3 significantly affected strain RS218’s ability to 
invade HBMEC (14, 98).   
Revisiting studies describing the multiple functions of OmpA and its diverse 
functions during NMEC pathogenesis is likely warranted.  OmpA alleles 4 to 7 all 
contain multiple polymorphisms in loops 1-3, many of which alter fundamental amino 
acid properties such as polarity and charge, and were already shown to have significant 
effects on NMEC HBMEC invasion (14, 98). 
NMEC harbor UPEC-like resistance patterns.  
Antimicrobial resistance gene screening was performed on isolates in this study.  
Overall, 47% of meningitis-causing E. coli strains in this study were genotype positive 
for at least one antimicrobial resistance gene.  The most common resistance genes were 
in the sulI family (37%), conferring resistance to sulfonamides; the blaTEM family 
(20%), conferring resistance to beta-lactamases; and the strAB genes (20%), conferring 
resistance to streptomycin (99).  Antimicrobial phenotype testing was previously 
performed on the 48 strains sequenced in this study and NMEC 58.  The resultant 
phenotypes were generally consistent with predicted genotypic resistance genes, except 
in the case of few specific antimicrobial agents.  Four strains, NMEC 82, 83, 84, and 91, 
were phenotypically resistant to streptomycin but harbored no gene known to encode 
streptomycin resistance.    Similarly, the tetracycline-resistance phenotype was found in 
seven strains, but no corresponding resistance gene was found for either tetracycline 
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degradation or ribosomal protection, nor tetracycline-resistant ribosomal sequences.  
While no specific resistance gene was found in corresponding strains, many also 
possessed uncharacterized putative ABC transporter systems, as well as characterized 
efflux systems that could account for antimicrobial resistance.  Similarly, specific 
resistance genes encoded on transmissible R type plasmids or in chromosomal integrons 
can be difficult to assemble in whole genomic sequencing due to high repetitive sequence 
content and multiple phage insertions, which could have caused removal from this 
analysis (100).  Finally, these phenotypic resistances could be caused by a novel anti-
microbial resistance gene, or an antimicrobial resistance gene not entered into the 
database.     
The overall incidence antimicrobial resistance for antimicrobial agents in the 
NARMS testing scheme was nearly identical to the resistance pattern seen in UPEC 
[unpublished data], and significantly less frequent compared to antimicrobial resistance 
phenotypes tested in APEC [unpublished data].  The lower occurrence of resistance genes 
in NMEC in comparison to APEC is likely due to differing antimicrobial exposure, as 
APEC strains are known to gain resistance genes after antimicrobial introduction in 
production facilities (101, 102).  Comparison of NMEC and UPEC strains shows 
remarkable similarity in resistance profiles, especially regarding sulfonamides, 
ampicillin, and streptomycin.  Sulfonamides, particularly 
trimethoprime/sulfamethoxazole, are currently advised for treating cystitis in the United 
States and is a second line treatment for pyelonephritis (103).   High resistance levels in 
UPEC is in agreement with these data, but NMEC strains phenotypically resistant to 
sulfisoxazole and cotrimoxazole (trimethoprim/sulfamethoxazole) is aberrant.  Though 
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sulfisoxazole and cotrimoxazole both reach high plasma concentrations and can penetrate 
the BBB, use in neonates and children below the age of 2 months is contraindicated.  
Studies performed in 1956 and 1959 (104, 105) showed sulfisoxazole caused increased 
levels of plasma bilirubin, possibly causing kernicterus and death.  These studies resulted 
in contraindication in both neonates and during pregnancy.  NMEC in this study were 
most commonly resistant to sulfisoxazole, with cotrimoxazole resistance being the fourth 
most prevalent.  The sulI gene encoding dihydropteroate synthase is present in all 
sulfisoxazole resistant strains, and is commonly encoded on resistance plasmids.  This 
indicates likely acquisition of resistance plasmids from UPEC strains, or could be an 
indication of UPEC strains as a common ancestor for some NMEC. 
Summary 
The population of NMEC strains sequenced in this study showed a heterogeneous 
mixture of virulence genes, and often lacked virulence factors thought critical to 
meningitis pathogenesis.  Further phenotypic analysis of the common NMEC virulence 
genes fimH and ompA revealed a high level of polymorphisms present in both proteins in 
sites that phenotypically alter their function.  This indicates that current knowledge of 
NMEC pathogenesis, which is largely based on analysis of one allele of fimH and ompA, 
may not accurately describe pathogenesis of all NMEC.  Comparison of polymorphic 
sites in populations of NMEC, UPEC, and APEC showed some polymorphic patterns are 
significantly associated with specific ExPEC sub-pathotypes.  Comparison of phenotypic 
and genotypic antimicrobial resistance predictions in NMEC strains were largely in 
agreement, though genotypic prediction of tetracycline and tetracycline resistance was 
highly inaccurate.  Finally, the overall antimicrobial resistance patterns of UPEC and 
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NMEC were highly similar, with predominant resistance to sulfonamides in NMEC likely 
indicating resistance plasmid transfer from, or recent common ancestry to, UPEC. 
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Abstract 
Neonatal Meningitis Escherichia coli (NMEC) is one of the most common causes 
of neonatal bacterial meningitis in the US and elsewhere resulting in mortality or 
neurologic deficits in survivors. Large plasmids have been shown experimentally to 
increase the virulence of NMEC in the rat model of neonatal meningitis.  Here, 9 
virulence plasmids with various genetic profiles were isolated from NMEC and 
sequenced to identify the core and pan plasmid genes of NMEC and create an expanded 
plasmid phylogeny.  Results showed NMEC virulence plasmids carry a strongly 
conserved core of genes with predicted functions in five distinct categories including: 
virulence, metabolism, plasmid stability, mobile elements, and unknown genes.  The 
major functions of virulence-associated and plasmid core genes serve to increase in vivo 
fitness by adding multiple iron uptake systems to the genetic repertoire to facilitate 
NMEC’s survival in the host’s low iron environment, and systems to enhance bacterial 
resistance to host innate immunity. Phylogenetic analysis based on these core plasmid 
genes showed that at least two lineages of NMEC virulence plasmids could be discerned. 
Further, virulence plasmids from Avian Pathogenic E. coli and NMEC plasmids could 
not be differentiated based solely on the genes of the core plasmid genome.  
 
Keywords: Avian Pathogenic E. coli (APEC), Extra intestinal pathogenic E. 
coli (ExPEC), Neonatal Meningitis E. coli (NMEC), Virulence plasmid, Virulence, 
Evolution 
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Importance 
Neonatal meningitis-associated Escherichia coli (NMEC) as well as some other 
types of extra intestinal pathogenic E. coli (ExPEC) are largely defined by the large 
plasmid; however relatively few NMEC plasmids have been sequenced and relatively 
few studies have examined their effects on pathogenicity.  In this study we sequenced 9 
plasmids from cases of neonatal bacterial meningitis to determine the core set of genes, 
and to determine if an evolutionary relationship between ExPEC plasmids exists.  Our 
results show the core plasmid genome of NMEC strains to include genes related to 
virulence and metabolism as well as a high degree of relatedness to other large ExPEC 
plasmids. 
Introduction 
Escherichia coli is one of the world’s most well-studied organisms.  Ubiquitous in 
nature and prevalent in biotechnology, it is also one of the most commonly isolated 
pathogens from human disease. Though some strains are specialized to cause disease 
inside the intestinal tract, others are equipped to cause extraintestinal disease (1, 2).  
These extraintestinal pathogenic E. coli (ExPEC) include neonatal meningitis E. coli 
(NMEC), one of the predominant agents of neonatal bacterial meningitis (3). Neonatal 
bacterial meningitis has a mortality rate between 15 to 40% (4) with 30% of survivors 
showing serious neurological sequelae including profound intellectual disability, 
epilepsy, or deafness (3).  Reviews suggest that NMEC are acquired by neonates from 
their mothers perinatally (4, 5). From the initial site of colonization, NMEC transcytose 
the gastrointestinal tract into the bloodstream, and from there, they traverse the blood 
brain barrier (BBB) (the tight barrier formed by human brain microvascular endothelial 
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cells (HBMEC)) into the central nervous system (CNS). Since successful CNS invasion 
requires a high bacteremia, NMEC must survive in the bloodstream, a trait that is 
mediated by two bacterial components, an anti-phagocytic capsule and outer membrane 
protein A (OmpA), which has an anti-complement role. In addition, NMEC’s replication 
in immune cells may play a role in achieving the requisite bacteremia. Also, NMEC’s 
traversal of HBMEC is preceded by its attachment to the BBB via Type 1 pili and OmpA, 
with invasion itself being mediated by Ibe proteins, FimH (tip adhesin of Type 1 pili), 
OmpA, and Cytotoxic Necrotizing Factor 1 (CNF1). K1 capsule may also contribute to 
invasion by preventing lysosomal fusion, allowing delivery of live bacteria into the CNS 
(4, 5).   
Plasmids also seem to contribute to NMEC virulence. A recent study by 
Kariyawasam and colleagues indicates that a large virulence plasmid increases the 
virulence of NMEC RS218 in vivo (6), while previous studies have shown that the 
acquisition of large virulence plasmids is one of the primary sources of genetic variance 
and virulence genes in different E. coli pathotypes  (7).  The majority of these plasmids 
has been identified as IncF- type plasmids, encoding pathogenicity islands, metabolic 
genes, antimicrobial resistance genes, and hypothetical genes.  Acquisition of these 
plasmids may provide an advantage for survival during infection and in suboptimal 
environments, as evidenced by multiple studies showing that these plasmids confer a 
fitness advantage to NMEC during in host tissues (6, 8, 9). Further, plasmids are 
associated with an increase in NMEC virulence in animal models (6, 8, 9), and cause 
cross-species and cross pathogenic group gain of virulence function (10).   
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Here, we seek to better understand the evolution of NMEC’s virulence plasmids 
and ascertain their similarity to other ExPEC plasmids.  While plasmids from NMEC 
strains S88 (O45:K1), S286 (O78:K1), RS218 (O18:K1) and CE10 (O7:K1) have been 
sequenced and are available in the public domain, it is our contention that the full 
diversity of NMEC plasmid sequences is not well documented.  We base this hypothesis 
on the variability found among NMEC in their possession of plasmid-associated genes 
(11).  We further contend that this knowledge gap could inhibit future study to identify 
rational strategies designed to control NMEC-caused disease.  We will address some of 
these shortcomings by sequencing a collection of diverse NMEC plasmids, identify 
orthologous genes shared between NMEC virulence plasmids in an effort to identify their 
core and pan plasmid genomes, ascertain the phylogenetic relationships between NMEC 
plasmids and determine their similarities to plasmids occurring in other ExPEC. 
Materials and Methods 
Bacterial Strains.   
A total of 11 E. coli isolates from cases of human neonatal meningitis were used 
as a source of plasmids in this study (Table 1). These isolates are part of a larger 
collection, containing 91 neonatal meningitis E. coli (NMEC) isolated from the 
Netherlands and United States.  The bacterial strains were serogrouped at the E. coli 
Reference Center (Pennsylvania State University), genotyped for chromosomal and 
plasmid virulence genes and plasmid replicon types, and assigned to phylogenetic groups 
as previously described (11-13).  
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Virulence Gene Amplification.   
As described in prior work, PCR was performed to determine the presence of 
chromosomal and plasmid-derived virulence genes (11, 14).  Briefly, all strains were 
removed from freezer stock and struck to MacConkey agar plates. Isolates were then 
transferred to LB broth and grown at 37°C overnight.  Bacterial DNA was harvested 
using the boil preparation method previously described (15).  For PCR analysis, isolates 
were tested for 205 genes associated with virulence and their allelic variants, 
antimicrobial resistance, plasmid replicons, and pathogenicity islands.  Primers were 
obtained from Integrated DNA Technologies (Coralville, Iowa). Replicon typing was 
carried out using the methodology described by Johnson (7) using multiplex PCR. 
Phylogrouping was carried out using the revised method of Clermont, assigning strains to 
8 phylogenetic groups (16). 
Selection of strains for sequencing  
Strains for sequencing were selected based initially on the presence or absence of 
nine known plasmid virulence genes (ompTp, hlyF, cvaC, etsA, iutA, iroN, tsh, iss, and 
sitC).  To be considered virulence plasmids in this analysis, plasmids must contain at 
least two known plasmid virulence genes.  Candidate plasmid-containing strains were 
further refined by the number of virulence genes detected by PCR, attempting to select 
for plasmids containing different combinations of virulence genes, as well as selecting 
plasmid containing strains originating from different serogroups, phylogenetic groups, 
and capsule types in order to capture the most possible depth.    
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Plasmid Isolation.   
The selected strains were grown overnight in 5ml of Luria Bertani (LB) broth, the 
bacterial cells pelleted by centrifugation, and their plasmid DNA isolated using  Qiagen 
midi plasmid prep kits according to manufacturer’s specifications (Venlo, Netherlands). 
The plasmid DNA pellet was re-suspended in Qiagen buffer EB.   Plasmid DNA 
concentration was measured using a NanoDrop 1000 (Thermo Scientific, Wilmington, 
DE).  
Plasmid separation was achieved using pulse field gel electrophoresis (PFGE) as 
described by Tivendale et al (6).  PFGE was carried out using a CHEF Mapper XA 
system (BioRad Hercules, California).  Plasmids were separated in 1.0% w/v Seakem 
Gold (Lonza, Bessel, Switzerland) agarose in a 0.5X TBE buffer (Invitrogen Carlsbad, 
CA).  Size controls used were pAPEC-O1-ColBM, pAPEC-O2-ColV, and pAPECχ7112.  
Electrophoresis was carried out at 6v/cm with an angle of 120° for 20h with an initial 
switch time of 1s and a final switch time of 20s (17).  Following electrophoresis, the gels 
were stained in distilled water containing 0.5mg/ml of ethidium bromide and de-stained 
in water as necessary.  All plasmids were visualized using UV transillumination.  
Individual plasmid bands were identified and excised using a clean straight razor and 
placed in 1.5 ml tubes.  The plasmids were dissolved in Qiagen buffer QG in an 
incubator-shaker at 37°C for 30 minutes to remove them from the agarose.   The 
dissolved gel fragments were subjected to sonication to fragment DNA below the 
maximum threshold for Qiagen column purification using a Diagenode Bioruptor 
Standard (Diagenode Seraing, Belgium) at high power using 30 second on/off cycles for 
5 minutes.  The samples were kept on ice before, during, and post sonication.  Post 
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sonication, DNA samples were purified as per the Qiagen protocol for PCR purification 
using manufacturer’s specifications and eluted from purification columns using 11ul of 
Qiagen buffer EB.  After purification, plasmids were quantified using the Q-bit 2.0 
Fluorometer using the q-bit HS assay kit (Life Technologies Carlsbad, CA) according to 
manufacturer’s specifications.   
Plasmid Sequencing.   
Paired-end plasmid DNA samples were prepared for sequencing by the Dana 
Farber/Harvard Cancer Center DNA Resource Core using the Nextera DNA sample 
preparation kit (Illumina San Diego, CA) according to manufacturer’s specifications for 
indexed multiplexing using 50ng of input DNA.  Input DNA was fragmented and tagged 
with the transposon, adding adapter sequences and allowing for amplification.  
Tagmented DNA was cleaned to remove any leftover transposon fragments.  Purified 
DNA was then PCR amplified for 8 cycles and purified of enzymes and DNTPs.  Library 
adapter ligation and amplification were tested by qPCR, and libraries were pooled.   
Library fragments in the size range of 500 to 600bp were selected using a Pippin Prep 
from Sage Science (Beverly, MA) according to manufacturer’s specifications.  
Sequencing of the tagged plasmids was carried out using an Illumina Mi-Seq machine 
(Illumina San Diego, CA) using a single lane.  Output files ranged in size from 1 to 5 GB 
and were quality trimmed based on the FASTq PHRED quality scores, cutting off at Q25 
and imported into the assembly software.  Velvet Optimizer 2.1.4 was used to determine 
optimal k-mer length and coverage cutoff. Plasmid assembly was achieved using Velvet 
short read assembler (version 1.2.03; European Bioinformatics Institute) for final 
assembly (18).  In general, most plasmids assembled into one to three large contigs with 
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few small contigs or contaminating sequences. Plasmid sequences requiring closure were 
closed using the previously sequenced pS88 as a backbone against which to assemble 
small contigs remaining from the Velvet assembly.    
Plasmid annotation was carried out for NMEC strains sequenced in this study and 
elsewhere using the Prokka automated annotation analysis pipeline in order to ensure 
consistency in our data.  The plasmids were annotated using the “-usegenus and –strain” 
options with a custom database generated from all APEC and NMEC plasmids in the 
NCBI database. 
Plasmid Core and Accessory Genome Analysis.   
The plasmid genomes of the fully sequenced NMEC plasmids from this study and 
those available online (11) were entered into an NCBI database, where an all-versus-all 
blast was performed to ascertain orthologous gene clusters (COGs).  Genes showing 
>90% sequence identity, e-values of lower than 1e-10, and overlap percentages of >90% 
were determined to be orthologous.  Orthologous genes were then sorted into strongly 
connected components using the algorithm of Tarjan in Perl (19).  Strongly connected 
components where an orthologous gene was present in each plasmid were grouped as 
members of a core gene set, while genes present in at least one genome were said to be 
members of the accessory genome.    
Plasmid Phylogenetic Analysis.   
Phylogenetic analysis was performed for the core genome of the NMEC and two 
APEC plasmids in order to compare different plasmids from different ExPEC sub-
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pathotypes.  Core genome nucleotide cDNA sequences were extracted from files, and 
concatenated to form a mega alignment using custom Perl scripts.  ClustalOmega (20) 
was used to align the nucleotide sequences and using default nucleotide settings and 
interleaved PHYLIP output.  The PHYLIP alignment was then used in seqboot from the 
PHYLIP software package to create 100 bootstrapped replacements in the tree, using the 
–m weights option.  This set of 100 weights was then used in the dnaml program from the 
PHYLIP software package to create a bootstrapped maximum likelihood tree using the 
parameters T=2.5, S, m,1.  The bootstrapped trees were then condensed using the 
consense program from the PHYLIP software package to give a consensus tree with 
bootstrap values using default parameters.  This tree was then reanalyzed in dnaml using 
the options –u, –t 2.5, to redraw branch lengths assuming the phylogeny was represented 
by the bootstrap inferred tree.  
Plasmid sequencing data accession numbers. Plasmid sequences were 
deposited in GenBank under numbers SAMN03580091 (pNMEC-14-ColV), 
SAMN03580092 (pNMEC-15-ColV), SAMN03580093 (pNMEC-16-ColV), 
SAMN03580094 (pNMEC-19-ColV), SAMN03580095 (pNMEC-26-ColV), 
SAMN03580096 (pNMEC 36-ColV), SAMN03580097 (pNMEC 38-ColV), 
SAMN03580098 (pNMEC-49), and SAMN03580099 (pNMEC-58-ColV). 
Results 
Strain Selection, Purification and Sequence Assembly.  
A total of 11 plasmids was sequenced from nine NMEC strains, each isolated 
from different patients.  Ten of eleven plasmid-containing strains were of the phylogroup 
102 
 
B2, and the dominant serogroup was O18:K1 (Table 1).  The source strains of these 
plasmids were previously assigned to clusters as described elsewhere (11) and were 
chosen for this study based on the diversity of the host strain serogroup, phylogroup, 
different virulence gene combinations, and cluster analysis.   
Multiple plasmids were recovered from some of the NMEC strains: NMEC 15 
and NMEC 36 both carried smaller cryptic plasmids. NMEC 15 contained a 114.75kb 
cryptic plasmid containing hypothetical and phage genes, while NMEC 36 carried a 
smaller 41.394 kb plasmid.   
Table 1:  Serogroups, phylogroups and genome statistics of selected sequenced NMEC strains used in 
the study.  
 
 
These plasmids contained a large number of hypothetical genes, as well as phage-related 
genes.  Since we wished to focus our study on the plasmids in NMEC that serve a role in 
virulence and that are considered to be one of the defining traits of the NMEC sub-
Plasmid Phylogroup O:K Cluster [1] Size (bp) GC% ORFs Source
pNM14  C 7:80 2 126,885 49.4 136 This Study
pNM15 B2 18:1 8 148,173 51.3 157 This Study
pNM16 B2 83:1 8 130,692 49.3 136 This Study
pNM19 B2 -:1 8 133,585 48.8 142 This Study
pNM26 B2 21:- 6 152,078 49.4 168 This Study
pNM36 B2 14:1 7 129,262 49.2 131 This Study
pNM38 B2 18:1 8 128,645 49.7 136 This Study
pNM49 B2 auto:1 8 121,081 49.6 119 This Study
pNM58 B2 18ac:1 8 157,260 49.7 157 This Study
pS88 B2 45:1 6 133,853 49.3 157 NC_011747.1
pS286 C 78:- - 97,818 48.6 104 HF922624.1
pAPEC-O1-ColBM B2 1:1 - 174,241 49.6 199 DQ381420.1
pAPEC-O2-ColV B2 2:1 - 184,501 49.2 203  AY545598.5
pAPEC-O103-ColBM B1 103:- - 124,705 50.8 126 NC_011964
p1ColV5155 B2 2:1 - 194,170 49.4 199 CP005930
pVM01 - -:28 - 151,002 49.5 150 NC_010409
pAPEC-1 B1 78:- - 103,275 45.1 164 CP000836
pAPEC-O78-ColV - 78:- - 144859 50.4 158 NZ_CP010316
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pathotype, all plasmids to be sequenced had to contain at least two plasmid-borne 
virulence genes from a list of nine commonly associated with large ExPEC virulence 
plasmdis (ompTp, hlyF, cvaC, etsA, iutA, iroN, tsh, iss, sitC).  Imposition of this selection 
criterion ensured that only plasmids containing some virulence associated genes would be 
included, and that cryptic or other plasmids were excluded. 
Nine of the 11 plasmids sequenced in this study passed quality control and 
selection criteria following annotation.  Two plasmids from strains NMEC 49 and NMEC 
84 had a lower depth of coverage, and contained segments of contaminating DNA, 
resulting in poor assembly and their subsequent exclusion from analysis beyond assembly 
(Table 1).  The plasmids pNM15c and pNM36c both contained fewer than three of the 
virulence-associated genes.  Further inspection of these plasmids showed that the 
majority of the plasmid genome consisted of hypothetical genes, phage genes, and genes 
of unknown function, and included no known virulence genes, and thus were also 
excluded from the analysis [Data not shown].  The resulting nine sequenced plasmids 
were combined with publically available NMEC plasmid sequences meeting the defined 
criteria described above, pS88 and pS286.   
NMEC Virulence Plasmid Accessory Genome.  
The virulence plasmid “accessory genome” of these 11 NMEC plasmids is 
defined as any COGs or single genes not found in the core genome, but present in at least 
one plasmid.  COGs from the accessory genome identified 123 putative genes present in 
at least two genomes, and 197 putative genes unique to only one plasmid.  Each gene’s 
description was derived from the consensus of the genes’ annotations.  The accessory 
genome consisted of 142 genes appearing in at least two plasmids (Figure 1) and 92 non-
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orthologous genes appearing in only one plasmid.  A heat map of the 142 genes present 
in two or more genomes is found in Figure S1. 
The plasmid accessory genome contained a large number of hypothetical genes, 
genes of unknown function, phage genes, and insertion sequences.  Other notable genes 
in the accessory genome included tsh the temperature sensitive hemagglutinin, and a 
homologue of the outer membrane protease ompT, though all plasmids carried another 
distinct copy of the ompT protease. 
 
Figure 1.  Genes of the NMEC plasmid accessory genome present in two or more plasmids organized 
into 8 functional categories based on protein prediction. 
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NMEC Plasmid Core Genome.  
To ascertain the range of extant genes in the plasmids of NMEC strains, all 
sequenced and annotated NMEC virulence plasmids passing selection criteria and two 
previously sequenced plasmids pS88 (21) and pS286 (22) were concatenated into a 
cDNA BLAST (22) database.  An “all versus all” blast analysis was performed to assign 
genes to clusters of orthologous groups (COGs), or groups of genes derived from a 
common ancestor.  COGs in which an ortholog from each plasmid was found were 
considered to be “core plasmid” genes and were further subjected to protein function 
analysis using the CombFunc pipeline (16).  Genes in the core genome were then 
categorized into eight functional categories based on known function or results from the 
combFunc pipeline (Table 2).  A core genome of 46 genes was predicted (see Figure 2).  
The core genome genes can be divided into five categories by putative functions: 
virulence associated; metabolic and signaling; unknown; plasmid stability and transfer; 
and mobile elements (Table 2).    
The virulence-associated genes of the NMEC plasmid core included all genes of 
the aerobactin (iutA/iucABCD), sit iron/manganese transporter (sitABCD), and 
salmochelin (iroBCDEN) operons.  All three of these operons encode high-affinity iron-
transport systems that are used by bacteria to obtain iron in low iron conditions such as 
those they encounter in host fluids and tissues. These operons have previously been 
reported in virulence plasmids of uropathogenic Escherichia coli (UPEC), APEC, and 
NMEC with high frequency and have been associated with ExPEC virulence.  Another 
gene found in the core genome of NMEC large virulence plasmids is iss. This gene 
encodes a protein linked with increased serum survival in human E. coli isolates.  
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Numerous studies have documented its strong alignment with virulent but not avirulent 
E. coli strains (23).  In addition, the genes ompT  
 
Figure 2. Visualization of NMEC plasmid core genome sites. Genes within the plasmid core genome are 
listed in the orange core genome section, while linear representations of the chromosomes of the NMEC 
plasmids are arranged in the circle.  Lines are drawn to the position of the core plasmid genes in their 
location within the plasmid to show core gene clustering. 
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Table 2:  Core plasmid genome of sequenced NMEC plasmids and their functions.  
Gene Name Description Function 
hlyF Hemolysin 
Virulence 
ompT Outer membrane protease 
Iss Increased serum survival protein 
iroB putative glucosyltransferase 
iroC ATP binding cassette ABC transport homolog 
iroD putative ferric enterochelin esterase 
iroE putative hydrolase 
iroN outer membrane receptor fepA 
iucA aerobactin siderophore biosynthesis protein 
iucB N(6)-hydroxylysine acetylase 
iucC aerobactin siderophore biosynthesis protein 
iucD L-lysine 6 monooxigenase 
iutA ferric aerobactin receptor precursor 
sitA iron/manganese transport, periplasmic-binding protein 
sitB iron/manganese transport protein ATP-binding component 
sitC Iron/manganese transport inner membrane component 
sitD iron/manganese transport protein, inner membrane 
component 
putative cobalamin synthase Putative Cobalamin synthase Metabolic 
and 
Signaling 
ssbL DHAP synthase for shikimate pathway 
truncated enolase putative enolase fragment 
crcB camphor resistance protein 
Plasmid 
Stability 
and 
Transfer 
repA RepFIB replication protein 
repA1 Plasmid replication protein 
repA2 Plasmid replication Protein 
traA conjugal transfer pilin subunit 
traE conjugal transfer pilus assembly protein 
traL conjugal transfer pilus assembly protein 
yacB putative plasmid stabalization system protein 
finO conjugal transfer fertility inhibition protein 
hypothetical mobile element putative mobile element protein/integrase 
Mobile 
Elements 
hypothetical phage protein hypothetical phage protein 
hypothetical transposase hypothetical transposase 
orfA transposase from plasmid origin 
hypothetical protein DNA Binding Function 
hypothetical protein DNA polymerase 
hypothetical protein Helicase activity 
Int Hypothetical integrase protein 
etsA putative type I secretion membrane-fusion protein 
Unknown 
etsB putative type I secretion ATP binding protein 
etsC putative type I secretion outer membrane protein 
shiF putative MFS family membrane transport protein 
hypothetical protein Unknown protein 
hypothetical protein Unknown protein 
yubQ putative transglycolylase 
hypothetical siderophore Putative Siderophore 
mig-14 putative Mig-14 protein 
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and hlyF are also found in the core genome of APEC’s large virulence plasmids.  ompT is 
predicted to encode a 42-kDa pro-protein, which is processed in the membrane to a 40k-
Da mature form.  Mature Iss functions as a narrowly specific outer membrane 
endoprotease (22) that 1) cleaves paired basic residues and is involved in membrane 
protein turnover, 2) can degrade interferon-gamma in-vitro (24),  and 3) cleaves the 
human defensin LL-37  (25). The hlyF gene is predicted to encode a putative hemolysin 
gene; however, the exact function of this gene is unknown. 
Metabolic genes of the NMEC plasmid core genome consists of three genes, ssbL, 
eno and a cobalamin synthesis gene. ssbL is a truncated enolase gene and a putative 
cobalamin (coenzyme B12) synthase gene. ssbL encodes a phospho-2-dehydro-3-
deoxyheptonate aldolase or DHAP synthase.  It is the first enzyme in a series of 
metabolic reactions known as the shikimate pathway, leading to the production of 
chorismate, which is responsible for the biosynthesis of the amino acids phenylalanine, 
tyrosine, and tryptophan and catecholate/phenolate siderophores. This gene co-locates 
with the iro operon in ExPEC plasmids (26).  The putative enolase gene found in the 
plasmid core genome is very small, comprising 33% of the eno gene from S88 at the C-
terminus at 51% identity. The eno gene catalyzes conversion of 2-phosphoglycerate to 
phosphoenolpyruvate (PEP) (27).  PEP is another reactant in the shikimate pathway for 
aromatic amino acid synthesis (28).  Finally, a putative cobalamin synthesis gene was 
also found.  This putative protein contains two domains homologous to cobalamin 
synthesis protein p47 metal binding motifs and may act as a chaperone in metal binding.   
Previous studies of APEC virulence have shown several vitamin synthesis pathways are 
crucial for APEC’s in vivo survival (29).    
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Nine genes comprise the third major gene group of the NMEC plasmid core 
genome.  These genes are responsible for plasmid transfer and stability and include 
replication genes (repA, repA1 and repA2), as well as finO, encoding an anti-sense RNA 
molecule inhibiting traJ (30) and the supercoiling and camphor-resistance gene crcB.  
The replication genes are responsible for control of plasmid copy number in cells and 
prevent replication by binding to plasmid sites, thereby inhibiting DNA replication.  This 
inhibition can be reversed by high dnaG expression (31-33).  Notably absent from this 
list are many of the tra genes from the type IV secretion system that responsible for 
plasmid conjugal transfer.  They do not show up in the core because they are not present 
in the plasmid pS286.   However, a case can be made for their inclusion since they occur 
in all others suggesting that pS286 is atypical, incomplete or aberrant.  Blast sequence 
comparison between crcB found in this study and all other E. coli found that the crcB 
genes of NMEC plasmids and UPEC strains UCI57, UCI58, KTE76, KTE102, KTE240, 
and E. coli 908585 are distinct from the crcB gene found in other E. coli, showing only 
53% amino acid identity.  Such differences suggest the possibilities of different binding 
ligands or function. Upon initial discovery, CrcB was indicated in plasmid supercoiling 
and resistance to camphor when overexpressed (34).  More recent studies show CrcB to 
be a putative membrane protein containing a metabolite-binding RNA structure, indicated 
to be fluoride in these studies, which can alter downstream gene expression (35).   
The NMEC plasmid core also includes mobile genetic elements and phage 
insertions.  Mobile element genes consists of phage genes, as well as transposable 
elements and integration proteins.  These elements recognize specific DNA sequences in 
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the plasmid, and can cause DNA transposition for incorporating virulence genes into 
pathogenicity islands. 
The NMEC plasmid core also includes genes of unknown function. The etsABC 
operon encodes a putative ABC transport system.  It is predicted that etsA encodes a 
putative membrane fusion protein, etsB encodes ATP-binding/permease protein, and etsC 
encodes an efflux protein. These genes are strongly associated with NMEC pathogenicity 
islands (11).  The shiF gene is a putative member of the COG0477 permease family.  The 
shiF gene homolog lies upstream of aerobactin synthesis genes; no evidence that its 
function is related to this aerobactin system has been found in E. coli. The gene yubQ 
encodes an X-polypeptide. It is a protein homologous to lytic transglycosylases (LT) of 
family four, thought to originate from phage (36).  This class of proteins in general is 
thought to act on the cell wall, degrading peptidoglycan into metabolites which can be 
recycled in the cytoplasm.  Most E. coli contain approximately seven distinct LT proteins 
with unknown functional differences.  LT proteins are essential genes in E. coli, deletion 
of all LT genes results in a lethal phenotype.  There are two hypothetical genes of 
unknown function that encode no known protein domains and the combFunc pipeline was 
unable to predict any functions of these proteins.  
Phylogenetic Analysis.   
The NMEC core plasmid genome was used to develop an ExPEC plasmid 
phylogeny.  To relate the evolution of these plasmids to other E. coli plasmids, three 
APEC plasmids, pAPEC-O1-ColBM, pAPEC-O2-ColV and pAPEC-O103 were included 
in the analysis (Figure 3).   These plasmids meet the same three criteria for inclusion as  
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Figure 3. Phylogeny of core NMEC plasmid genes and APEC plasmid genes.  Alignment was based on 
concatenation of core genes shared between APEC and NMEC plasmids.  Genes were identified using an 
all-versus-all nucleotide blast using the blastn algorithm using default parameters.  Blast matches sorted 
into strongly connected components using Tarjan’s algorithm.  Nucleotide sequences from strongly 
connected groups were extracted in a randomized order and concatenated.  Bootstrap analysis was 
performed using Phylip seqboot algorithm creating 10 sets of 10 weights using default parameters, which 
were then used in 10 separate runs of dnaml using the parameters T 2.5, S, M, 1.  Phylip consense was 
used to condense all output trees into a consensus bootstrap analysis using default parameters 
described above and were included in the analysis to better understand differences 
between plasmids from different ExPEC sub-pathotypes.  However, UPEC plasmids were 
not included in this analysis as no publically available sequenced UPEC plasmids met 
inclusion criteria.  The APEC/NMEC core plasmid genome consisted of 15 genes 
(21,496bp), containing the iro and iut operons as well as replication proteins repA and 
repB, which was used to generate a plasmid phylogeny.  Additionally, one outlier was 
observed in this analysis: pAPEC-O103, which is a hybrid plasmid containing a 
pathogenicity island and multi-drug resistance island and lacking the complete tra 
operon.  As a result of this analysis, it appears that there are at least two lineages of 
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NMEC virulence plasmids.  In addition, as a result of the comparative analysis, it appears 
that APEC and NMEC plasmids cannot be differentiated solely based on the presence or 
absence of genes in a core genome of plasmid.  
Discussion 
The contributions made to ExPEC pathogenesis by large virulence plasmids has 
received increased scrutiny in recent years.  In part, this scrutiny is due to creation of the 
reagents needed for their study, such as plasmid genomic sequences (6, 9, 21, 26), and 
dissemination of new plasmid isolation protocols that enabled harvesting of large, 
naturally occurring plasmids from wild-type bacterial strains (37).  Previous to that the 
presence of large ExPEC plasmids was likely overlooked (14).  Here, in an effort to 
define the core and accessory genome of NMEC plasmids, nine new plasmids isolated 
from NMEC were sequenced.  Plasmids were selected so as to enrich the diversity of 
NMEC plasmid sequences available in the public domain and in order to describe the 
broadest core and accessory genome.  Despite this emphasis on diversity, clusters 5 and 9 
contained only a single isolate, while clusters 2 and 3 primarily consisted of human fecal 
E. coli biasing the strain selection towards groups 6-8, which were determined to be the 
most pathogenic and most common clusters for NMEC in the analysis (11).  Efforts were 
made to sequence strains from different serogroups where multiple options existed, 
attempting to capture the dominant O-types of O18, O83, and O7, while still sequencing 
representatives from less common serogroups, such as O14, O21, as well as untypeable 
NMEC.  Selecting for strains outside of the predominant B2 phylogroup is difficult, as 
our collection of 94 NMEC isolates contains predominantly B2 strains (78%), with the 
next most common phylogenetic group being F, representing 6.8% of the isolates in the 
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full 91 sample collection.  Finally, K type was used if all other parameters from the 
analysis were the same, which included one strain of the K80 type in the analysis, as well 
as multiple untypeable capsules.  The previously published NMEC plasmids pRS218 and 
pCE10 were excluded from the analysis due to the absence of all virulence genes used to 
define a virulence plasmid in this study.  Further analysis of strain CE10 showed the 
iutABCD and sitABCDC genes are present in the chromosome, while RS218 did not 
possess any of these virulence genes on the plasmid or the chromosome. 
Assembled plasmids varied largely in terms of size, but surprisingly had similar 
GC content and numbers of open reading frames, indicating that a large proportion of 
these plasmids may not encode functional proteins.  This seems to be borne out by the 
significant number of hypothetical genes in the accessory genome of the NMEC 
plasmids.  It is unclear whether this result suggests that some plasmids are accumulating 
genetic information that is not used, or whether they have not yet shed excess genetic 
information that may not be functional or whether these hypothetical or pseudo genes 
have an unknown function.  Classical genes related to antibiotic resistance were not 
found in any of these plasmids, with only one plasmid harboring a single putative 
antibiotic resistance gene.  The lack of resistance genes is corroborated by the lack of 
multiple drug resistant strains in our NMEC collection (38), as well as those available 
publically for other NMEC strains.  Furthermore a complete and intact transfer region 
was not found on all of the NMEC plasmids, suggesting these plasmids lost the 
transmissible capability during the evolution course. 
The core genome of the NMEC plasmids contains 46 genes, most of which 
encode components of iron uptake systems.  Iron uptake systems are necessary for the 
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full virulence of septicemia-associated E. coli (6, 11, 21), uropathogenic E. coli (39), and 
avian pathogenic E. coli (12, 14, 40, 41). Although it has not yet been reported, this study 
suggests that iron acquisition is important for NMEC virulence since human serum and 
cerebrospinal fluid (CSF) are also iron-deficient environments.  Indeed, the presence of 
iron acquisition genes in NMEC isolates has been well established (6, 11) and NMEC, 
UPEC, and APEC share a similar content of iron uptake systems that are not found in 
non-virulent fecal E. coli strains from both human and animal sources (11). Moreover, 
unpublished data from our group has found that the expression of several iron uptake 
systems was significantly upregulated when NMEC were cultured in human serum and 
CSF compared to strains cultured in LB (Unpublished data). The data presented here 
indicate that three iron uptake systems, the ferric aerobactin system (iutA/iucABCD), the 
salmochelin siderophore system (iroBCDEN), and SitABCD system, have been 
associated with ExPEC virulence, and are encoded by core the genome of NMEC large 
virulence plasmids.  Interestingly, the metabolism gene (ssbL) found in the core genome 
of NMEC virulence plasmids appears to be co-located with these iron genes.  This ssbL 
gene encodes a putative DHAP synthase which may boost production of aromatic amino 
acids via the shikimate pathway by increasing concentrations of available precursor 
molecules.  Aromatic amino acids are necessary for large amount production of 
enterobactin, salmochelin SX, and yersiniabactin (26).  The finding of ssbL gene in the 
core genome of the NMEC virulence plasmid appears to reinforce the importance of the 
iron uptake system for NMEC virulence. 
Based on the findings published thus far, NMEC’s ability to cause meningitis 
requires at least two major steps and one of them is intravascular multiplication leading to 
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high-level bacteremia. Thus, NMEC must be able to resist or avoid the detrimental 
impact of the host complement, antimicrobial peptides, polymorphonuclear leukocytes, 
and other specific and innate immunity factors. In the core genome of NMEC virulence 
plasmids, the iss gene was found, which is homologous to the bor gene of bacteriophage 
λ. The Iss protein increases E. coli’s serum survival likely by restricting C3 deposition on 
the bacterial surface (23) and blockage of the membrane attack complex (42). Another 
core genome gene of the NMEC virulence plasmid involved in resistance to innate 
immunity is ompT. The ompT gene encodes an outer membrane protease (22) that can 
degrade interferon-gamma. More recent studies on ompT in enteropathogenic E. coli 
(EPEC) and enterohaemorrhagic E. coli (EHEC)  showed ompT cleaves the human 
defensin LL-37 (25), a pore forming antimicrobial peptide expressed by neutrophils, 
epithelial cells, and bone marrow that serves both antimicrobial and immunomodulatory 
functions. The ompT gene in the core genome of NMEC virulence plasmids shares 
approximately 74% of amino acid identity to those encoded by EPEC and EHEC. Thus, it 
could be inferred that OmpT can degrade interferon and human antimicrobial peptide 
increasing NMEC’s resistance to human innate immunity, thus contributing to NMEC’s 
pathogenesis. In addition, several other accessory genome genes of NMEC virulence 
plasmids were found to contribute to NMEC’s resistance to host immunity. The gene tsh, 
which has been previously reported to be an important virulence factor for closely related 
APEC strains and is present in 11 to 50 percent of NMEC samples, encodes a protein 
able to cleave leukocyte glycoproteins, impair chemotaxis and transmigration, and 
activate leukocytes’ programmed cell death (43).   
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The homolog of CrcB was shown to be involved in the chromosome condensation 
and plasmid supercoiling, causing a secondary effect of resistance to camphor, which 
decreases chromosome condensation (34). Overexpression of the gene increases 
chromosomal condensation and can correct nucleoid morphology defects in some 
mutants, and may help these large plasmids partition into daughter cells. As we know the 
E. coli chromosome, like its eukaryotic counterparts, must be condensed approximately 
2000-fold to fit inside an E. coli cell.  Given the large size of the virulence plasmids for 
NMEC, it is likely that the CrcB gene carried on the plasmid is necessary to fit the 
plasmid into the cells, and may increase the likelihood of the plasmid successfully 
passing to daughter cells post replication. 
In conclusion, this is the first study to define the core and pan NMEC plasmid 
genome, and perform a phylogenetic analysis of NMEC large virulence plasmids. The 
role of the core genome of NMEC plasmids is likely to increase the bacteria’s in vivo 
fitness by enhanced uptake of iron in a deficient environment, increase resistance to host 
innate immunity, as well as maintain the plasmid in the bacterial population with systems 
for conjugation and plasmid stability. Phylogenetic analysis of the NMEC plasmids 
shows that at least two lineages can be discerned and they are nearly indistinguishable 
from those of the APEC plasmid. We hope this and future studies lead to a better 
understanding of the molecular mechanisms by which NMEC large plasmids contribute 
to virulence and their evolution. 
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Abstract 
Neonatal meningitis E. coli (NMEC) is a common agent of neonatal bacterial 
meningitis, causing high neonatal mortality and neurologic sequelae.   Here, we present 
the complete genome sequence of NMEC O18 (also known as NMEC 58), a highly 
virulent O18ac:K1 serotype and B2 phylogenetic group strain of NMEC from the ST416 
sequence type.  NMEC O18 has been shown to cause 91% mortality in the rat model of 
human neonatal meningitis. 
Genome Announcement 
Neonatal bacterial meningitis (NBM) is a devastating disease of newborns.  NBM 
occurs during the first four weeks of life (1, 2).   NMEC are the second leading cause of 
NBM (1), and predominantly infect newborns after four days of life (2), but can cause 
disease in newborns less than one day of age (2).  NBM rapidly progresses in the infant 
with empiric treatment often performed before a definitive diagnosis of meningitis is 
reached (3). Reported mortality rates vary from 10% to 50%, based on study location, 
gestational age, and weight of the neonate (2, 4).  Survivors of NBM often suffer severe 
neurological sequelae that may include seizures, hearing loss, cerebral palsy, and delayed 
development, occurring in 12% to 44% of survivors (5).  
 NMEC O18 has been characterized in the rat model of meningitis.  In neonatal 
rats, it caused 91% mortality at 24 hours post infection, with mortality observed as early 
as 14 hours (6).   NMEC O18 shares the same serogroup and phylogenetic group as the 
prototypic NMEC strain, NMEC RS218.  Unlike NMEC RS218, NMEC O18 contains 
additional genes encoding aerobactin synthesis as well as the outer membrane proteins 
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OmpTp, HlyF, and Iss but lacks the gene encoding cytotoxic necrotizing factor 1 found in 
NMEC RS218 (7, 8).  Similar to RS218, NMEC O18 contains a large virulence plasmid 
carrying genes encoding multiple siderophores and other virulence factors.  NMEC O18’s 
high degree of virulence, despite deviating from the well-described pattern of virulence 
factors found in NMEC RS218, makes NMEC O18 an interesting candidate for future 
studies into NMEC pathogenesis. 
NMEC O18 is a member of the O18:K1 serotype, the B2 phylogenetic group and 
the ST 416 sequence type (6).  NMEC O18 was isolated from the cerebrospinal fluid of 
an infant with neonatal bacterial meningitis in the Netherlands (6).  NMEC O18 genomic 
DNA was subjected to genomic sequencing using Roche/454 FLX genome and Illumina 
Hi-Seq 2000 sequencers, followed by hybrid assembly.  The following datasets were used 
in the final assembly: (i) GS-FLX, with 456,508 paired reads and 213,580 shotgun reads 
totaling 128 Mb (~26-fold coverage) and (ii) Illumina 100 bp paired-end library with 
15,458,728 reads totaling 1,236 Mb (~247-fold coverage).  Both 454-read sets were 
assembled de novo using Newbler 2.6 (Roche), and Illumina reads were assembled 
separately with Velvet 1.1 (8).  The genome was closed using 454 scaffolds against 
NMEC strain S88 sequence for velvet assembly.  Whole-genome optical mapping 
(OpGen, Gaithersburg, MD) was used to validate scaffolds and contig order. The 
assembly was confirmed using PCR and Sanger sequencing and validated by consistency 
of paired-end evidence from 454 and Illumina reads. 
The assembled genome consists of a single chromosome (5,002,781bp; 50.75% 
GC content) and a single plasmid (153,378bp; 48.49% GC content).  The chromosome 
contains 4,659 protein-encoding genes and 90 tRNA-genes. 
124 
 
Acknowledgement 
This work was supported by grant USDA-NIFA award 0826675 and grant NIH award 
007134-00001. 
 
References 
1. Heath PT, Nik Yusoff NK, Baker CJ. 2003. Neonatal meningitis. Arch Dis 
Child Fetal Neonatal Ed 88:F173-178. 
2. Gaschignard J, Levy C, Romain O, Cohen R, Bingen E, Aujard Y, Boileau P. 
2011. Neonatal Bacterial Meningitis: 444 Cases in 7 Years. Pediatr Infect Dis J 
30:212-217. 
3. Sivanandan S, Soraisham AS, Swarnam K. 2011. Choice and duration of 
antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr 
2011:712150. 
4. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily 
P, Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ, 
Shane AL, Zell E, Schrag SJ. 2011. The burden of invasive early-onset neonatal 
sepsis in the United States, 2005-2008. Pediatr Infect Dis J 30:937-941. 
5. Stevens JP, Eames M, Kent A, Halket S, Holt D, Harvey D. 2003. Long term 
outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 88:F179-184. 
6. Tivendale KA, Logue CM, Kariyawasam S, Jordan D, Hussein A, Li G, 
Wannemuehler Y, Nolan LK. 2010. Avian-pathogenic Escherichia coli strains 
are similar to neonatal meningitis E. coli strains and are able to cause meningitis 
in the rat model of human disease. Infect Immun 78:3412-3419. 
7. Khan NA, Wang Y, Kim KJ, Chung JW, Wass CA, Kim KS. 2002. Cytotoxic 
necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central 
nervous system. J Biol Chem 277:15607-15612. 
8. Wang MH, Kim KS. 2013. Cytotoxic necrotizing factor 1 contributes to 
Escherichia coli meningitis. Toxins (Basel) 5:2270-2280. 
 
125 
 
CHAPTER 5.  COMPLETE GENOME SEQUENCE OF THE AVIAN 
PATHOGENIC ESCHERICHIA COLI STRAIN APEC O18 
 
An article for submission to the journal Genome Announcements 
 
 
 
Bryon A. Nicholsona, Yvonne M. Wannemuehlera, Catherine M. Loguea, Ganwu Lib, and 
Lisa K. Nolana 
 
aDepartment of Veterinary Microbiology and Preventive Medicine, College of Veterinary 
Medicine, VMRI 2, Iowa State University, Ames, Iowa, USA 
bDepartment of Veterinary Diagnostic and Production Animal Medicine, College of 
Veterinary Medicine, 1802 University Blvd., Iowa State University, Ames, Iowa, USA; 
126 
 
Abstract 
Extra intestinal pathogenic Escherichia coli (ExPEC) are responsible for some of 
the most widespread and consequential diseases of human and animal hosts.  Genetic 
similarities between human and avian ExPEC strains plus similarities in the mechanisms 
by which they cause disease have led to suspicion that some ExPEC are zoonotic 
pathogens.  Especially notable in this regard are Neonatal Meningitis E. coli (NMEC) and 
Avian Pathogenic E. coli (APEC).  Here, we document the first fully closed genomic 
sequence of an Avian Pathogenic E. coli strain of serogroup O18.  APEC O18 shows 
potential as a zoonotic pathogenic capable of causing neonatal meningitis in human 
newborns.  
Genome Announcement 
APEC O18 is a serotype O18 sequence type ST95 strain isolated from the 
pericardial and lung tissue of a case of colibacillosis in Nebraska.  APEC O18, previously 
labeled APEC 380, has been characterized in the chicken model of colibacillosis, where it 
caused 80% mortality at 24 hours and in the rat model of neonatal meningitis, where it 
causes 75% mortality at 24 hours (1).    
Genomic sequencing was performed using complementary sequencing 
technologies, combining results obtained from a Roche/454 FLX genome sequencer (GS) 
instrument and an Illumina Hi-Seq 2000. The following datasets were used in the final 
assembly: (i) GS-FLX, with 152,602 paired reads and 423,865 shotgun reads totaling 155 
Mb (~31-fold coverage) (ii) Illumina 100 bp paired-end library with 11,193,121 reads 
totaling 839Mb (~168-fold coverage). Both 454-read sets were assembled de novo using 
127 
 
Newbler 2.6 (Roche), and Illumina reads were assembled separately with Velvet 1.1 (2). 
The genome was closed using 454 assemblies as a “reference” sequence with the 
Illumina data used to add depth, correct errors, and close gaps. Whole-genome optical 
mapping (OpGen, Gaithersburg, MD) was used to validate scaffolds and contig order. 
The assembly was confirmed using PCR and Sanger sequencing and validated by 
consistency of paired-end evidence from 454 and Illumina reads. 
The assembled genome consists of a single chromosome (5,006,568 bp; 50.70% 
GC content) containing 4,674 protein-encoding genes and 85 tRNA-carrying genes.  The 
APEC O18 is larger than previously sequenced strains APEC O78 and APEC χ7122 and 
shares similarities to strain APEC O1, a strain which does not cause disease in the 
meningitis model.  Genomic comparisons of this isolate with other sequenced ExPEC 
genomes is ongoing.  
Acknowledgement 
This work was supported by grant USDA-NIFA award 0826675 
 
References 
1. Tivendale KA, Logue CM, Kariyawasam S, Jordan D, Hussein A, Li G, 
Wannemuehler Y, Nolan LK. 2010. Avian-pathogenic Escherichia coli strains 
are similar to neonatal meningitis E. coli strains and are able to cause meningitis 
in the rat model of human disease. Infect Immun 78:3412-3419. 
2. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly 
using de Bruijn graphs. Genome Res 18:821-829. 
 
128 
 
CHAPTER 6.  CONCLUSION AND DISCUSSION 
 
Pathogenic E. coli are an exceptionally diverse group of organisms highly 
adaptable to a wide range of environments, hosts, and host sites.  Pathogenic E. coli 
thrive in these environments due to their large and variable genetic content, encoding 
adhesins, invasion factors, toxins, nutrient acquisition, and protection systems.  Often 
these pathogenic systems are redundantly encoded, such as in the case of iron acquisition, 
possibly to enhance fitness in differing environments, or for reasons currently unknown.  
This diversity and functional redundancy is especially prevalent in extra intestinal strains, 
leading scientists to suggest ExPEC strains cannot be characterized by single 
representative isolates as this cannot encompass their breadth of diversity.   Nearly all 
studies into the functionality of NMEC are based on strain RS218 or mutants thereof.  
While NMEC typically possess a serotype and capsule similar to RS218, these traits are 
by no means universal.  Similarly virulence gene content varies widely between strains of 
NMEC.  This focus on RS218 has created a narrow view of NMEC pathogens.  When 
this narrow view is examined with genomic epidemiology of a larger set of NMEC 
strains, serious gaps in knowledge of pathogenesis become apparent.  While all the 
research of strain RS218 has given insight into the virulence mechanisms of NMEC, 
factors such as K1 capsule, S fimbriae, Cnf1, and IbeA are not universally present in 
NMEC.  Perhaps the most suggestive data supporting NMEC diversity is NMEC strain 
NMEC O18, a highly pathogenic strain of NMEC that does not invade macrophages as 
other reported strains of NMEC, but is still highly pathogenic. The differences in 
genotypes and phenotypes between NMEC strains are highly suggestive that more study 
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is needed regarding the current model of NMEC pathogenesis and that multiple routes of 
pathogenesis exist in NMEC.  Regardless, analysis and characterization of differing 
NMEC strains should be a high priority. 
Further care must be taken when examining virulence factors such as fimH and 
ompA, genes common to nearly all E. coli and different E. coli pathotypes where 
polymorphic sites are known to greatly influence phenotypes.  This research has shown 
that in NMEC, multiple and very distinct alleles of both FimH and OmpA exist in 
NMEC.  While these alleles have not been tested in NMEC, their study in adherent-
invasive E. coli and UPEC shows polymorphisms correlated with altered phenotypes in 
binding and receptor specificity.  
Plasmids are another area of pathogenesis requiring more study.  Our studies 
ascertained little to no differences in virulence in strain NMEC 58 when the large RepFIB 
virulence plasmid was removed [Unpublished data], indicating that in NMEC 58, the 
virulence plasmid may not be necessary to cause meningitis, NMEC strain RS218 when 
tested without its virulence plasmid showed significant attenuation, even though strain 
RS218 and NMEC 58 share extremely recent common ancestry. 
In conclusion NMEC are important pathogens of humans, and while some 
information is known about their pathogenicity, further characterization of NMEC should 
include more strain diversity to broaden our understanding of the pathogen and the 
disease or diseases they cause. 
 
 
